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Abstract   
Background 
In the unwell child who is unable to feed orally, various methods for enteral 
feeding having been advocated. The ideal method for a particular child has to 
be tailored according to his/her anatomy, physiology and requirements. The 
impact of complex medical background on outcomes and complications 
following a surgical procedure in children remains largely unrecognized. 
Aims 
1. To determine whether percutaneous endoscopic gastrostomy (PEG) is 
superior to radiologically inserted gastrostomy (RIG) 
2. To determine outcomes following surgical jejunostomy (SJ) or 
radiologically inserted gastro-jejunal (RGJ) tube 
3. To study complications after surgery and determine its effect  
Methods 
A double-blinded randomised controlled trial was conducted in children 
needing gastric feeding, who received either a PEG or RIG. They were 
followed up for up to 3 years to record any complication. 
Retrospective reviews of buried bumpers (a specific complication of 
gastrostomy), and the nutritional outcomes following jejunostomy placement 
(SJ or RGJ) was carried out.  
Available scoring systems for post-operative complications were reviewed 
and initial development of a new paediatric complexity scoring system was 
performed. 
Results 
In the trial 198 children were randomised (100 PEG and 98 RIG). They were 
followed up to a median of 1 year (6 weeks to 3 years). There was no 
difference between total number of complications or the rate of 
complications, following PEG or RIG. 
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Both SJ and RGJ are able to maintain and improve growth in a carefully 
selected group of children. 
There is a need for validation of a developed paediatric complexity scoring 
system. 
Conclusions 
PEG and RIG have equivalent rates of complications. 
SJ and RGJ cannot be compared as they are used for patients at different 
stages in a spectrum of malnutrition. 
Impact of the complexity of paediatric patients on their post-operative 
complications needs thorough consideration to improve outcomes. 
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Impact Statement 
PEG vs. RIG Trial 
The major work in this thesis is a randomised controlled trial of percutaneous 
endoscopic gastrostomy (PEG) versus radiologically inserted gastrostomy 
(RIG). In a retrospective study, RIG was found to have more complications 
than PEG, suggesting that RIG should not be performed. However, the 
double blinded randomised control trial performed and analysed in this thesis 
found no difference in number or rate of complications following PEG or RIG. 
This has important impact on centres practising both methods of gastrostomy 
insertion, leading to streamlining of patient treatment to the more readily 
available option without any concerns about difference in outcomes. Further 
study of this cohort of patients can provide information about the 
development of gastro-oesophageal reflux, need for further feeding device or 
resolution of symptoms and establishment of oral feeding.  
The publication of the trial in British Journal of Surgery (2017;104(12): 1620-
1627), will further disseminate and provide robust, scientific evidence about 
the efficacy of PEG and RIG. 
Buried bumper 
This is a major, life threatening complication after a gastrostomy. I reviewed 
this complication in a large cohort of children. I realised that the design of the 
gastrostomy and care are major contributing factors for developing a buried 
bumper. I have recommended maintaining a prospective registry and 
changing a bumper gastrostomy device to a balloon gastrostomy sooner. 
The publication of the findings in European Journal of Pediatric Surgery 
(2013; 23(1):76-79), has increased awareness and provided management 
options to clinicians and parents. 
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Jejunal feeding 
Jejunal feeding for children unable to tolerate gastric feeds can be achieved 
by surgical jejunostomy (SJ) feeding tube or radiologically inserted gastro-
jejunal (RGJ) feeding tube. I reviewed complications and nutritional outcomes 
following jejunostomy placement (SJ or RGJ). I have reviewed different 
factors i.e. patient’s medical background, practicality of caring for the device, 
local resources available and complications. The review published (Pediatric 
Surgery International 2018; 34(9):951-956), will provide information to 
families while they are being counselled for the choice of jejunal tube. They 
should be able to make an informed decision along with the clinician. 
I have recommended a prospective randomised controlled trial, with a 
sample size to detect a difference in complications/outcomes after anti-reflux 
operation or gastro-jejunal tube feeding in neurologically impaired children. A 
formal quality of life assessment for the patient and caregivers is also 
needed.   
Complication Scoring 
Reporting of complications in children is not standardised. The adult 
complication reporting systems do not account for a child’s physiology and 
the complexities of other medical/surgical pre-existing conditions. Impact of 
the complexity of paediatric patients on their post-operative complications 
needs thorough consideration to improve outcomes. I have developed the 
Paediatric Complexity Index (PCI). It requires further development and 
extensive validation. 
I have had discussions with researchers involved in developing Patient 
Reported Outcome Measures at Oxford for adults. With their experience, this 
work can be taken forward to develop a similar model in children. This 
requires funding and pooling of resources from clinicians (paediatric 
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anaesthetists, intensivists and surgeons) to non-clinicians (health 
economists, psychologists, statisticians and website development specialist). 
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1.1 Physiology of feeding 
Hunger is one of the most primitive instincts that has led to survival and 
evolution of a species. The sensation of hunger is associated with craving for 
food and physiological effects such as rhythmic contraction of the stomach 
and restlessness, causing a person to look for food. A person’s appetite 
makes one desire a certain type of food thus influencing the quality of food 
eaten. These two mechanisms are important automatic regulatory systems to 
ensure adequate nutritional supply for the body. However, the body needs an 
intact ingestion and swallowing mechanism as well.  
Swallowing is a complex mechanism (Figure 1-1), as the pharynx is primarily 
used for respiration and it is only for a few seconds that it acts as a conduit 
for passage of food into the stomach. Swallowing can be divided into different 
phases:  
Figure 1-1 Swallowing mechanism   
(Reprinted with permission from Elsevier-Guyton) 
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1.1.1 Voluntary oral phase 
This consists of the food bolus being voluntarily pushed into the pharynx by 
the tongue. When the food is ready to be swallowed, the tongue pushes the 
bolus by pressing upwards and backwards against the palate. 
1.1.2 Pharyngeal phase 
As the food bolus comes into contact with the highly sensitive tactile area at 
the back of the mouth, the swallowing reflex is initiated. The soft palate is 
pulled upwards closing the nasal cavity and the pharynx is pulled upwards 
and forwards, which together with the backward movement of the epiglottis 
closes the trachea for a few seconds. Sensory input via the Trigeminal and 
Glossopharyngeal nerves reach the swallowing centre in the medulla 
oblongata and lower pons. Motor impulses to the pharynx and upper 
oesophagus reach via the Trigeminal, Glossopharyngeal, Vagus and 
Hypoglossal nerves from the swallowing centre, resulting in contraction of the 
pharyngeal muscles and propulsion of the food bolus into the oesophagus. 
1.1.3 Oesophageal phase 
The peristaltic waves from the pharynx continue into the oesophagus as 
primary peristaltic wave propelling the food bolus downwards into the 
stomach. If these are not enough to push all the food that has entered the 
oesophagus into the stomach, then secondary peristaltic waves arise. These 
are partly a continuation of the primary peristaltic waves and partly a reflex 
initiated from the distension of the oesophagus stretching the intrinsic 
myenteric plexus (Arthur C Guyton, 2006). 
1.2 Pathology of children needing artificial feeding 
Children have an increased nutritional requirement to support their rapid 
growth and development. There are a number of conditions in which children 
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are unable to maintain an adequate nutrition and need artificial 
feeding/support. They can be broadly divided into two groups, due to:  
i. Inadequate intake 
ii. Inadequate absorption 
1.2.1 Inadequate intake 
Psychological – due to depressed ‘hunger’ or ‘appetite’ centre in the 
hypothalamus. Children with severe behavioural and gastrointestinal 
disorders have greatly benefitted from artificial feeding devices (Sathesh-
Kumar et al., 2009, Nah et al., 2010) 
Neurological - conditions such as epilepsy, encephalopathy, cerebral palsy 
etc. can result in uncoordinated swallowing. Due to the unsafe swallow these 
children have a high risk of aspiration (Sleigh et al., 2004, Townsend et al., 
2008, Vernon-Roberts et al., 2010). Objective assessment of swallowing can 
be done using Videofluoroscopic Swallowing Study (VFSS) or Fibreoptic 
Endoscopic Evaluation of Swallowing (FESS). Both procdures examine the 
swallowing mechanism under conditions that mimic eating. The VFSS is 
ussually carried out by speech and language therapist and radiologist. The 
FESS is carried out by speech and language therapist and gastroentologist 
or otolaryngologist. After careful assessment, artificial feeding into the 
stomach with or without an anti-reflux procedure or into the jejunum is often 
needed. 
Chemotherapy – Highly emetogenic chemotherapy results in stimulation of 
the Chemoreceptor trigger zone in the medulla oblongata, which in turn 
excites the ‘vomiting’ centre (Figure 1-2). Children undergoing or due to 
undergo intense chemotherapy are unable to maintain adequate oral intake 
due to the intractable nausea and vomiting (Aquino et al., 1995, Schmitt et 
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al., 2012, Pedersen et al., 1999, Mathew et al., 1996). 
 
Figure 1-2 Chemoreceptor Trigger Zone and the vomiting centre in the medulla 
oblongata  
(Reprinted with permission from Elsevier-Guyton) 
Increased demand - Children with metabolic disorders or renal failure require 
unpalatable medications or feeds in large volumes. An assisted feeing device 
can ensure compliance in such cases. 
As a part of other surgical procedure - Children requiring a definite and 
secure means of enteral feed as a part of another surgical intervention such 
as cleft palate repair, complex cardiac surgery (Urban and Terris, 1997, Al-
Attar et al., 2012). 
1.2.2 Inadequate absorption 
This can be due to short length of functional bowel or immature bowel or 
ileus as in inflammatory bowel disease, necrotizing enterocolitis, short bowel 
syndrome, prematurity, post major abdominal surgery. 
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1.3 Types of artificial feeding 
1.3.1 Enteral route 
The route for artificial feeding whether it is for supplementation or complete 
diet replacement depends on the functional status of the gastrointestinal 
tract, nutritional and psychological state of the patient. It is always best to use 
an enteral route (Figure 1-3) for nutrition if the intestine works and is of 
adequate length.  
The commonly used enteral feeding routes are nasogastric / orogastric, 
nasoduodenal and nasojejunal route as short-term measures.  Nasogastric 
tube is indicated for children with inadequate or unsafe oral intake, post 
operatively after major upper gastrointestinal surgery and absent gag reflex. 
Nasojejunal feeds are indicated in children with severe gastro oesophageal 
reflux, delayed gastric emptying and persistent vomiting. For longer term use 
gastric or jejunal feeding routes are preferred. The major disadvantage of 
Figure 1-3 Enteral routes   
(Reprinted with permission from Baxter)  
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nasal route of tube feeding is that it can be pulled out by the child and lead to 
aspiration. In the long-term it can lead to oral food aversion. 
1.3.2 Parenteral route  
If the gastrointestinal tract is not functioning, then it can be bypassed and 
nutrients can be supplied intravenously. The administration of nutrients in 
high concentration requires access to a central vein. This can be through a 
tunnelled catheter or a sub cutaneous port into the subclavian vein (Hickman 
line®, Port-a-Cath) or via a central venous catheter (CVC) into the subclavian 
or internal jugular vein or through a peripherally inserted central catheter 
(PICC) into the superior vena cava (Figure 1-4, 1-5). 
 
Figure 1-5 Tunnelled 
Hickman®/Broviac® line 
(Reprinted with 
permission from Medical 
Dictionary © 2009 Farlex 
and Partners) 
Figure 1-4 Routes of administration of parenteral nutrition  
 
(Reprinted with permission from Baxter)  
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The parenteral route should not be used in the presence of an intact and 
functional gastrointestinal system. The disadvantages of using the parenteral 
route are: 
i. Risk of life threatening infection 
ii. Non-use of the gastrointestinal tract can lead to atrophy and loss of 
function 
iii. Metabolic disturbances such as: hypo/hyperglycaemia, electrolyte 
disturbances 
iv. Risk of developing fatty liver leading to liver failure 
v. Cost: parenteral nutrition costs four times more than enteral nutrition 
As soon as bowel function returns, children on parenteral nutrition should be 
weaned to enteral feeding. Even many children with Short Bowel Syndrome 
and enteropathy can be weaned off parenteral nutrition over time. 
1.4 Description of enteral feeding methods 
1.4.1 Naso-enteric 
Nasogastric / Nasoduodenal / Nasojejunal (Figure 1-3): These are used for 
short term enteral feeding (usually less than 3 months). The advantage is 
these are easily reversible, can be inserted without a general anaesthetic and 
has a low cost. It does need an X-ray to confirm the position. However, the 
major disadvantage is that it gets inadvertently pulled out by a baby/child, 
which if occurs during feeds can lead to aspiration. This can lead to repeated 
bouts of chest infections sometimes serious enough to warrant intensive care 
unit admission. Long-term dependency on tube feeding is known to lead to 
oral food aversion (Wilken et al., 2013). The other often overlooked aspect is 
the social stigma associated with a tube visible on a baby’s face (Avitsland et 
al., 2012). Some practical problems are sore anterior nares, rash on the 
cheek due to sticky tape and repeated attendance to the Emergency 
department for replacement of a pulled tube. 
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1.4.2 Gastrostomy 
History  
Gastrostomy is one of the oldest performed operations on the stomach. In 
1635, Daniel Schwaben performed a gastrostomy, to remove a knife, which 
was swallowed by accident. It was not intended to be a gastrostomy, but a 
gastric fistuIa was formed, thus becoming a gastrostomy (Spivack, 1945). 
Christian A Egeberg was the first to describe gastrostomy formation in a 
patient with oesophageal stricture in 1837. His surgical technique was 
followed for a few decades (Cunha, 1946). Since then, there have been more 
than thirty different techniques described. New techniques were modifications 
to prevent the major complications of leakage, peritonitis and occasional 
detachment of the stomach from the abdominal wall. No technique was 
perfect. 
Figure 1-4 Original paper describing PEG in Journal of Pediatric Surgery (Gauderer et 
al., 1980) 
However, in 1980, Gauderer et al described percutaneous endoscopic 
gastrostomy (PEG), which was a major breakthrough in the evolution of this 
seemingly simple procedure (Gauderer et al., 1980) (Figure 1-6). He 
successfully performed and reported the formation of a percutaneous 
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endoscopic gastrostomy in twenty-six children, including two infants, one 
weighing 2.5kg. 
Figure 1-5 Original paper describing RIG in American Journal of Roentgenology (Tao 
and Gillies, 1983) 
In 1983, another minimally invasive technique of radiologically inserted 
percutaneous gastrostomy (RIG) was introduced (Tao and Gillies, 1983, Wills 
and Oglesby, 1988) (Figure 1-7). Both these procedures obviated the need 
for a laparotomy for gastrostomy insertion. Over the last three decades it has 
become one of the commonest performed procedures in infants and children. 
More recently, laparoscopic assisted gastrostomy tube placement has 
become popular. This enables visualisation of the gastrostomy device on 
either side of the stomach (Gauderer, 2013). 
Indications 
Gastrostomy is used primarily for long term feeding in infants and children. It 
is also used for decompression along with an anti-reflux procedure, for 
administration of medications and for placement of transpyloric jejunal 
feeding tube (Gauderer, 2013). 
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The three commonly used methods for gastrostomy formation are: 
i. Serosa lined channel from the anterior gastric wall to the skin surface 
around a catheter: Stamm technique 
ii. Percutaneous technique in which the introduced catheter keeps the 
gastric wall in apposition to the anterior abdominal wall: PEG/RIG  
iii. Laparoscopically assisted technique for either of the above  
 
Stamm gastrostomy:  This involves a laparotomy and placement of purse-
string sutures around the gastrostomy tube producing an invagination lined 
with serosa (Figure 1-8). The stomach is usually anchored to the anterior 
abdominal wall with sutures. The idea is to form a watertight seal around the 
gastrostomy. 
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Figure 1-6 Stamm gastrostomy (Gauderer, 2013) 
 (Reprinted with permission from Operative Pediatric Surgery, 7th Edition CRC Press) 
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Figure 1-7 Percutaneous Endoscopic Gastrostomy  
(Reprinted from Operative Pediatric Surgery, 7th Edition (Gauderer, 2013), with permission 
from CRC Press) 
 
Percutaneous Endoscopic Gastrostomy (‘pull’ technique): In a young child 
this is placed under a general anaesthetic with endotracheal intubation, 
however in the older child/adolescent this can be placed under sedation and 
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local anaesthetic. After insufflation of the stomach with an endoscope, 
indentation of the stomach and transillumination through the abdominal wall 
is confirmed under endoscopic vision. A small incision is made over the area 
of maximum transillumination and a catheter mounted on a needle passed 
through followed by a guidewire. The guidewire is grasped by the endoscope, 
pulled out through the mouth and attached to the gastrostomy tube which is 
then pulled antegrade and out through the abdomen (Figure 1-9). The tube is 
fixed with an external fastener and no sutures placed. In children with severe 
scoliosis, anatomic variation of the stomach being placed cranially into the 
left chest is possible. The transverse colon also sits at a higher position, 
thereby more liable to be injured by the needle. Extreme caution should be 
exercised and the operator should have a low threshold to convert to open or 
laparoscopic assisted method (Gauderer, 2013). 
 
 
 
Figure 1-8 Schematic diagram of RIG placement using antegrade technique 
Radiologically Inserted Gastrostomy: This can be inserted using antegrade or 
retrograde technique. In the antegrade technique the gastrostomy tube is 
pulled down the oesophagus (Figure 1-10), while in the retrograde technique 
it is pushed into the stomach through the anterior abdominal wall. In both 
techniques biplane fluoroscopy (Malden et al., 1992), with pre-placement 
ultrasonography for localization of the liver is used. In the antegrade 
technique, an orogastric snare is passed and the stomach punctured under 
fluoroscopic guidance with an 18-gauge trocar needle, which is used to insert 
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a guidewire. This is snared and withdrawn through the mouth. The snare 
catheter is introduced in a retrograde direction from the abdominal wall to the 
mouth, and the gastrostomy tube is grasped and pulled down the 
oesophagus.  
In the retrograde technique, the stomach is punctured in the same manner, 
but a needle pre-loaded with a suture anchor device may be used instead of 
the trocar needle. These temporary retention devices help to hold the 
stomach in apposition against the anterior abdominal wall as the tract is 
dilated. A locking pigtail catheter or balloon device is then inserted. These 
can get displaced with more ease than a flanged device, but they are easier 
to remove or exchange once the tract is mature (Roebuck, 2013). 
 
Laparoscopic assisted gastrostomy: There are several combinations of using 
laparoscopy for gastrostomy formation: with open (Stamm/ ‘push’ technique 
modification) or as video assisted PEG. 
1.4.3 Gastro-jejunostomy  
There is a high degree of foregut dysmotility in neurologically impaired 
children. This often results in significant gastro oesophageal reflux, which 
leads to failure to tolerate gastric feeding. These children can be offered a 
range of anti-reflux procedures. However, this is usually a major undertaking 
in the child with neurological impairment and decreased respiratory reserves. 
These children usually have a pre-existing gastrostomy and a jejunal tube 
through the gastrostomy may prove to be the solution (Al-Zubeidi et al., 
2013). The gastro-jejunostomy is a relatively simple procedure in the hands 
of the radiologists and is performed without an anaesthetic. However, the 
trans-gastric jejunal tubes are not ideal for long-term use, as they frequently 
get displaced back into the stomach (Fortunato et al., 2005) and might need 
numerous trips to the radiology department for replacement.  
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1.4.4 Jejunostomy  
Long-term access to the proximal small bowel for enteral feeding can be 
beneficial in children with neurological impairment not tolerating gastric 
feeds. It can also be useful in the care of children with acute surgical 
problems benefitting from early enteral nutrition (such as major trauma, 
burns, children needing long-term supplemental feeding) (Gauderer, 2012). 
 
Figure 1-9 Different types of jejunostomy  
(Reprinted from Pediatric Surgery, 7th Edition(Gauderer, 2012) with permission from Elsevier 
Saunders) 
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Figure 1-10 Roux-en-Y feeding jejunostomy with a balloon-type access device  
(Reprinted from Pediatric Surgery, 7th Edition (Gauderer, 2012) with permission from Elsevier 
Saunders) 
In most cases jejunostomy formation requires a laparotomy (Figure 1-11, 
Figure 1-12), however, in the older child percutaneous endoscopic 
jejunostomy (PEJ) is possible. Jejunostomies can be formed under 
radiological guidance by an interventional radiologist as well (Hoffer et al., 
1999, Wales et al., 2002). Laparoscopy is increasingly being used for 
jejunostomy formation (Young et al., 2016). 
1.5 Complications (literature review) 
1.5.1 Gastrostomy 
Since the description of PEG in 1980 (Gauderer et al., 1980), this has 
become the gold standard for the creation of a gastrostomy. It has obvious 
advantages over the ‘open’ gastrostomy insertion, which are less operative 
time, no incision therefore less pain and early establishment of feeds. 
However, all gastrostomies have complications. A review of the literature for 
complications following gastrostomy insertion is difficult. The available 
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studies are summarized in Table 1-1. The complications described as ‘major’ 
in one series might be ‘minor’ in another. Hence the studies are not 
comparable. For the purpose of uniformity in the review of series detailing 
complications, I have defined major complications as: 
i. any complication requiring a general anaesthetic (either laparotomy or 
endoscopy), 
ii. blood transfusion or  
iii. non-prophylactic antibiotic treatment; 
iv. death. 
Gastro oesophageal reflux (GOR) has been included as a ‘major’ 
complication in some of the series, the argument being that the insertion of a 
gastrostomy alters the anatomy of the stomach, which might make GOR 
worse in some cases and give rise to GOR de novo as well. In children with 
neurological impairment and complex medical conditions, gastro 
oesophageal reflux disease (GORD) is a spectrum of evolving disease. The 
volume and speed of feeds infused also affects GOR. It is difficult to 
definitively establish that a gastrostomy is responsible for GOR in these 
children. It might well be a part of the natural history of their inherent disease, 
due to which there is an apparent association of GOR with gastrostomy. To 
this effect there are conflicting results from trials conducted in paediatric and 
adult patients (El-Matary, 2008). In the paediatric literature, Grunlow et al 
(Grunow et al., 1989) concluded that PEG insertion leads to significant GOR; 
while Launay et al and Wilson et al (Launay et al., 1996, Wilson et al., 2006) 
concluded that PEG placement does not increase GOR. 
The series which have been published in the 1990s are most likely soon after 
the introduction of PEG technique and therefore probably have a low 
threshold for conversion to open procedure and may also have a higher 
complication rate. 
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1.5.2 Jejunostomy 
There is very little data on the long-term follow up and complications after 
jejunostomy, in adults or children. The available studies in the paediatric 
population are summarized in Table 1-2. As with gastrostomy studies, the 
definition of ‘major’ complications is not uniform and therefore not 
comparable. Gastro-jejunal tubes have been reported to be inconvenient as 
long term feeding tubes due to the need of device re-insertion after frequent 
dislodgement (Godbole et al., 2002). 
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1.6 Scientific analysis of complications 
1.6.1 Background 
Historically, mortality has been the measure to assess the risk of surgical 
procedures (Clavien et al., 1992). However, with the improvement in post-
operative care and better survival, factors such as morbidity, quality of life 
and cost have become more important. In 80% of the reported studies 
describing complications there is no mention of the severity (Martin et al., 
2002). The reporting of complications is inconsistent and incomplete. There 
is lack of standardization of complications and consequent under-reporting. A 
‘minor’ complication by one might be classed as ‘moderate’ complication by 
another. This also leads to difficulties in surgical comparative trials and other 
studies, where incidence of complications is compared between procedures, 
where it might be concluded that a procedure with frequent minor 
complications is inferior to a procedure with infrequent, but life-threatening, 
complications. 
1.6.2 Categorization of Adverse Events 
 In 1992 an attempt to differentiate ‘complications’ from ‘failure to cure’ and 
‘sequelae’ was made (Clavien et al., 1992). Complications were classed 
according to the degree of invasiveness of the treatment needed to correct 
the complication.  
1.6.3 Clavien-Dindo classification  
In 2004, Clavien and Dindo modified the classification, leading to the Clavien-
Dindo classification. It describes five grades of severity for most known 
complications (Table 1-3) (Dindo et al., 2004). Usually the single most severe 
complication is reported, while ‘ignoring’ others. It therefore does not 
represent the overall morbidity of a procedure. However, it is simple, very 
easy to replicate and can be used in different parts of the world consistently. 
Introduction 
 
41 
This classification has been used extensively in numerous studies across 
various surgical fields, especially in adults. 
 
 
Table 1-3 Clavien-Dindo classification for surgical complications (Dindo et al., 2004) 
1.6.4 Comprehensive Complication Index (CCI) 
To report the overall morbidity after a surgical procedure, the CCI was 
developed (Slankamenac et al., 2013). The authors conducted a series of 
studies to develop and validate a unique comprehensive scoring system, 
based on the well-established Clavien-Dindo classification. It includes all 
negative events that occur after a procedure, with their respective severity. 
CCI weights severe complications more heavily than multiple complications 
of lesser severity. Low-grade complication contributes less and less in 
combination with more severe complications in the overall post-operative 
assessment. It is reproducible for analysis and can detect clinically relevant 
signs. It promises to be a readily assessable (www.assessurgery.com) and 
easily reproducible method of quantifying the overall burden of postoperative 
complications. 
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The CCI has been developed and validated on a wide spectrum of adult 
patients undergoing a variety of major and minor general surgical 
procedures. However, it has not been validated on paediatric patients and 
may not be pertinent to the complex paediatric patient. It should only be used 
with caution to evaluate complications in paediatric surgical patients.  
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Aims & Objectives 
My overall aims in this thesis are to investigate different enteral feeding 
methods and their complications in children.  
The specific objectives were: 
(i) to determine the better method of gastrostomy insertion, with 
the hypothesis that percutaneous endoscopic gastrostomy (PEG) is 
superior to radiologically inserted gastrostomy (RIG) – by 
undertaking a randomised controlled trial  
(ii) to investigate a major complication of percutaneous 
gastrostomy - specifically buried bumpers – by reviewing the 
incidence, associated risk factors, treatment and prevention 
strategies 
(iii) to investigate jejunal feeding methods – specifically surgical 
jejunostomy feeding and radiologically inserted gastro jejunal feeding 
in terms of risks and benefits and nutritional outcomes 
(iv) to compare scoring systems to quantify patient outcome in a 
prospectively collected patient sample – specifically Clavien Dindo 
scoring, Comprehensive Complication Index and PEG vs. RIG 
scoring system 
(v) to develop a novel tool to measure morbidity in the paediatric 
surgical patient – a preliminary study to develop a Paediatric 
Complexity Index (PCI) for risk stratification of paediaric surgical 
complications. 
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Chapter 2 Randomised 
controlled trial of gastrostomy 
techniques: The PEG vs. RIG Trial 
  PEG vs. RIG Trial 
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2.1 Background 
Percutaneous endoscopic gastrostomy (PEG) is a widely used and well 
accepted method for gastrostomy insertion in children (Gauderer et al., 1980) 
Radiologically-inserted gastrostomy (RIG) has similarly become widely 
accepted (Tao and Gillies, 1983). Although both techniques require a general 
anaesthetic, RIG has a potential advantage from a service provision point of 
view in that an operating theatre slot is not required, so that waiting times for 
gastrostomy may be shorter. A retrospective review conducted by Nah et al. 
(2010) of 331 children who had a gastrostomy inserted between May 2004 
and July 2008, showed that the overall complication was lower in PEG as 
compared to RIG (28% vs. 47%, P=0.001) (Figure 2-1). They also concluded 
that oncologic patients, the younger child and those with higher weight z-
scores were more likely to have complications. However, the study being 
retrospective has the inherent disadvantage of the two study populations 
being unmatched. The PEG group of patients were mostly neurologically 
impaired, while the RIG group of patients had mostly oncological or 
gastrointestinal disease. The latter group are more likely to be immuno-
compromised and on chemotherapeutic agents, making them prone to 
complications such as delayed healing and infections (Barron et al., 2000). 
The other significant problem was the different referral pathway for PEGs and 
Figure 2-1 Complications after PEG and RIG from Nah et al. (2010) 
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RIGs at the hospital. The authors attempted to take account for these 
differences by using zero-inflated Poisson regression analysis but concluded 
that ‘RIG patients still had a higher complication rate than did PEG patients. 
Nevertheless, such conclusions should ideally be confirmed by a randomized 
controlled trial’.  
 
2.2 Hypothesis 
The hypothesis to be tested is that percutaneous endoscopic gastrostomy 
(PEG) is superior to radiologically inserted gastrostomy (RIG) in terms of 
outcome and complications. 
2.3 Aim of the study 
The aim of this trial was to investigate this hypothesis by conducting a 
randomised controlled trial. Both PEG and RIG have the benefits of easy 
insertion and avoidance of a laparotomy incision. However, both techniques 
are also associated with complications, including gastro-colic fistula, 
haemorrhage, buried bumper and intra-abdominal leak with sepsis (Wollman 
et al., 1995, Cosentini et al., 1998, Vervloessem et al., 2009, Campos and 
Marchesini, 1999, Singh et al., 2013). Although there are a number of 
publications on both methods in the adult population (Wollman et al., 1995, 
Cosentini et al., 1998, Barkmeier et al., 1998, Leeds et al., 2010, Blondet et 
al., 2010), there is little information available in the literature specifically 
comparing the two techniques in the paediatric population. A recent 
Cochrane review highlighted the lack of evidence in this area, as no 
randomised controlled trials comparing PEG with RIG were identified, either 
in adults or in children (Yuan et al., 2016). 
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2.4 Methods 
2.4.1 Participants 
The PEG vs. RIG trial was a double-blinded single centre randomised 
controlled trial. Two hundred and fourteen patients (n = 107 in each arm) 
were randomised to either PEG or RIG. I co-ordinated the trial, consented 
and randomised patients. As I also co-ordinated the booking of PEG or RIG 
onto the relevant operating list, it was not feasible for me to be blinded. The 
patient and parents or guardian were blinded to the method of gastrostomy 
insertion used. To ensure the blinding of the patients and assessors, I used a 
standard information sheet and consent form. The operation note was placed 
in a sealed envelope in the clinical notes. The post-operative gastrostomy 
wound for either PEG or RIG was dressed similarly. All patients and their 
caregivers were counseled after the procedure by the same specialist 
gastrostomy nurses who were not part of the trial, at which they were given 
standardized post-gastrostomy care advice and an information pack. Routine 
clinical follow up was performed as per normal practice. 
The research nurses assessing the outcomes (complications) were also 
blinded. For the assessment at follow-up of the patients, I organised training 
of the research nurses at the Somers Clinical Research Facility in Great 
Ormond Street Hospital. These nurses had no access to the patients’ clinical 
notes. I also designed a standard follow-up questionnaire to aid this 
(Appendix 3). 
The recruitment started in November 2011 and finished in November 2014. 
2.4.2 Inclusion Criteria 
The inclusion criterion was defined as:  
1. any child referred for gastrostomy insertion (including those with 
medically treated gastro-oesophageal reflux). 
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These patients were under the care of various clinical teams including: 
General Surgery, Oncology, Haematology, Endocrine, Metabolic, 
Gastroenterology and Nephrology. 
2.4.3 Exclusion Criteria  
Patients were excluded from the trial if they:  
1. had gastro-oesophageal reflux and were being considered for anti-
reflux surgery including fundoplication 
2. had previous gastrostomy or fundoplication 
3. had previous extensive abdominal surgery or 
4. required a concomitant major procedure on the gut or other intra-
abdominal organs. 
There were no specific age or weight inclusion/exclusion criteria, but in 
order to be eligible, both the interventional radiology and surgical teams 
had to be potentially willing to perform the procedure. 
2.4.4 Ethical Approval 
The trial had ethical approval from the National Research Ethics Service 
(NRES) of the Health Research Authority. The registration number is: 
10/H0713/47 
The trial was registered with the ClinicalTrials.gov. ClinicalTrials.gov is a 
Web-based resource that provides patients, their family members, health 
care professionals, researchers and the public with easy access to 
information on publicly and privately supported clinical studies on a wide 
range of diseases and conditions. The National Library of Medicine (NLM) at 
the National Institutes of Health (NIH) maintains the Web site. 
ClinicalTrials.gov Identifier: NCT01920438 2013. 
The research was conducted in accordance with the Declaration of Helsinki 
(2001).  
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2.4.5 Randomisation 
Patients were allocated to groups (1:1 allocation ratio) by weighted 
minimisation (Treasure and MacRae, 1998, Wade et al., 2006). 
Minimisation is a method of randomised treatment allocation, which ensures 
that the groups are balanced with respect to prognostic indicators 
(minimisation criteria) that are likely to affect patient outcome. This is based 
on the idea that the next patient to enter the trial is given whichever treatment 
would minimise the overall imbalance between the groups at that stage of the 
trial. The patients were randomised online using a fast and simple method 
(SiMin® Window-based software, developed by the Institute of Child Health, 
UCL) to either PEG or RIG. The software was installed on a single password-
protected computer, which was accessible only by me.  
Minimisation criteria used are detailed in Table 2-1. The criteria were based 
on the conclusions of Nah et al. (2010) of children with certain diagnosis, 
younger age and greater weight being prone to complications. To avoid the 
operational confounders of pathway of patient referral the inpatient status is 
Minimisation 
Criteria Definition 
Diagnosis 
[Neurological] [Haematology/Oncology] 
[Metabolic] [Gastrointestinal Diseases] 
[Miscellaneous] 
Age [< 6months] [6 months – 2 years] [2 – 5 years] [>5 years] 
Weight Centile [<3%] [3-10%] [10-25%] [25-50%] [>50%] 
Inpatient Status [Yes] [No] 
Scoliosis [Yes] [No] 
Gastro-
esophageal reflux [No] [Yes- Not needing anti-reflux surgery] 
Table 2-1 Minimisation criteria 
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one of the criteria as well. It is widely recognised that children with difficult 
anatomy such as in scoliosis and with pre-existent gastro - oesophageal 
reflux might have more complications. So the six minimisation criteria used 
would make the two treatment groups very comparable. 
2.4.6 Treatments and Schedules 
When an eligible patient was identified, I discussed the trial with the parents 
and obtained informed consent. Patients were then randomised to either 
PEG or RIG. Procedures were performed by consultant radiologists or 
paediatric surgeons or by trainees at specialist registrar level under direct 
supervision by a consultant on site. All consultants had extensive experience 
with either RIG (interventional radiology consultants) or PEG (general surgery 
consultants). All cases were done under general anaesthesia with 
prophylactic antibiotics (co-amoxiclav unless contraindicated) administered 
before the procedure. A 9 French silicone gastrostomy tube was used (Freka, 
Fresenius, Runcorn, UK) which is approved (CE Marked) and marketed in 
the UK and EU. 
 
The two standardized procedures compared in the trial were: 
a) Percutaneous Endoscopic Gastrostomy (PEG) 
After insufflation of the stomach with an endoscope, indentation of the 
stomach and transillumination through the abdominal wall was confirmed 
under endoscopic vision. A small incision was made over the area of 
maximum transillumination and a catheter mounted on a needle passed 
through followed by a guidewire. The guidewire was grasped by the 
endoscope, pulled out through the mouth and attached to the gastrostomy 
tube which was then pulled antegrade and out through the abdomen. The 
tube was fixed with an external fastener and no sutures were placed. 
 
b) Radiologically Inserted Gastrostomy (RIG) 
Oral contrast was given the night before the procedure to line the colon on 
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the day of procedure; enemas were not used. The stomach was insufflated 
with air via the nasogastric tube. Glucagon was not routinely used, although 
whether it was to be used or not was not stipulated in the protocol, and one 
interventional radiologist used glucagon as standard practise, whereas the 
others only used glucagon if it was difficult to delineate the stomach. RIG was 
performed using biplane fluoroscopy (Malden et al., 1992), with pre-
placement ultrasonography for localization of the liver. An orogastric snare 
was passed and the stomach punctured under fluoroscopic guidance with an 
18-gauge needle, which was used to insert a stiff 0.035-inch guidewire.  This 
was snared and withdrawn through the mouth. The snare catheter was 
introduced in a retrograde direction from the abdominal wall to the mouth, 
and the gastrostomy tube was grasped and pulled down the oesophagus. 
The stages of the trial were as follows: 
Stage 1 – Enrolment 
i)  Patient was identified as eligible 
ii)  Informed consent was obtained from parents or guardian 
iii) Demographics recorded and treatment randomised via 
randomisation software 
Stage 2 – Day of Procedure 
Details of operative procedure (technical failure, difficulty of procedure, 
operator details) 
Stage 3 – Postoperative period 
Data was collected until discharge of the patient from hospital. 
Stage 4 – Postoperative Follow-up 
Patients were re-evaluated at 6 weeks ± 2 weeks, 6 months± 1 month, 
1 year ± 2 months and 3 years ± 2 months after the procedure. 
Complications were recorded and scored. 
If by the time of evaluation, the participant had the gastrostomy 
removed, and there was no clinical indication for follow-up, the 
evaluation was stopped.  
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2.4.7 Outcome Measures 
The primary end point of the study was the total number of complications 
(major and minor). 
 
The secondary end points of the study were defined as:  
i. major complication rate : colonic injury or gastro-colic fistula or other 
visceral injury, peritonitis requiring surgery, intestinal obstruction requiring 
surgery, major gastrointestinal bleed, other complications requiring 
surgery (including buried bumper) 
ii. minor complication rate : infection requiring systemic antibiotics, delay 
more than 48 hours in establishing feeds, granulation, wound site 
discharge, tube-related problems (migration, dislodgement, leakage, 
breakage), other minor  
iii. complication score : this is a score devised with weighting assigned to 
each complication depending on the severity of the complication, as 
detailed in Table 2-2. The score was devised in a consensus meeting 
attended by experts in the field (paediatric surgeons, interventional 
radiologists, junior doctors and specialist nurses). 
iv. technical failure : these are the number of PEG or RIG that are 
unsuccessful and require conversion to open surgical gastrostomy or 
laparoscopic gastrostomy. 
v. cost of hospital treatment 
vi. mortality 
vii.  cause of death (relatedness to procedure / primary disease) 
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Table 2-2 Gastrostomy scoring system for complications of gastrostomy insertion 
 
 Type of complication Score 
Major 
complications 
Colonic injury / gastro-colic fistula 20 
Peritonitis requiring surgery 20 
Intestinal obstruction requiring surgery 20 
Major gastrointestinal 
bleed 
Requiring surgery 20 
Requiring transfusion but not 
surgery 10 
Buried Bumper 20 
Other complications requiring surgery 20 
Minor 
complications 
Infection requiring systemic antibiotics 1 
Delay more than 48 hours in establishing feeds 1 
Granulation 1 
Wound site discharge 1 
Tube-related problems 
Migration 1 
Pulled out / dislodged 5 
Leakage around tube 2 
Breakage 2 
Other minor 2 
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2.4.8 Sample Size  
The sample size was based on the primary end point of complications and 
was determined using the best available evidence at the start of the trial. This 
was based on the previous retrospective review of 331 children who had 
either PEG or RIG (Nah et al., 2010). The review showed that 28% of PEG 
patients and 47% of RIG patients had complications (Figure 2-1). 
For sample size estimation, we used a binary superiority power calculation, 
i.e. proportion of patients with any complications in each group.  
To detect a difference of 19% (80% power, significance level =0.05), 100 
patients per group were needed. 
At Great Ormond Street Hospital, a large number of gastrostomies are 
performed per year (between 3-5 per week), and it was estimated that 200 
patients would be recruited within 2 years. 
2.4.9 Trial Management 
There was some delay in starting the trial, to ensure agreement between the 
researchers, Somers Clinical Research Facility and Research & 
Development (R&D) Office. To set-up the randomized controlled trial I had 
discussions with the Interventional Radiology and General Surgery 
operational units. I also had discussions with the Somers Clinical Research 
Centre and the Research & Development (R&D) governance team. Ethical 
amendments were obtained to alter the original protocol in order to correct 
and clarify various details of the study, and also to include a follow-up 
window. These were approved by the ethics committee and by the R&D 
team. The recruitment began in November 2011 and finished in November 
2014.  
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The trial involved recruitment of patients needing a gastrostomy. The patients 
were under the care of various clinical teams including: General Surgery, 
Oncology, Haematology, Endocrine, Metabolic, Gastroenterology, and 
Nephrology. I organised departmental meetings and discussion with the 
clinicians involved in the care of the patients. I had one-to-one discussions 
with the nephrologists, oncologists, gastroenterologists, haematologists and 
general surgeons about individual patients. I put up flyers in the outpatient 
clinics providing more information. 
Initially, it was difficult to schedule patients for their procedure once recruited 
and allocated, but I had discussion and meetings with the operators involved 
and the process was streamlined. Since then the process ran effectively and 
there was no delay in patients receiving a gastrostomy. 
I managed the trial on a day-to-day basis. I assessed each referral for a 
gastrostomy against the inclusion and exclusion criteria. If the exclusion 
criteria were absent, I contacted the parents or caregiver of the referred child. 
I gave detailed information about the trial and addressed any concerns. If the 
child was judged to be of suitable age and maturity, I made every attempt to 
provide as much information as appropriate to the child regarding 
participation. I obtained informed consent for inclusion in the trial and 
consequently for randomisation. I randomised the patient online using 
SiMin® software to either PEG or RIG. Once randomised, I secured 
operating space for either PEG or RIG. I made sure that the interventional 
radiologist or general surgeon who performed the gastrostomy, were aware 
that the patient was in the trial and the group allocation is not disclosed. As I 
was co-ordinating the placement of PEG or RIG and their subsequent follow 
up by research nurses, I could not remain blinded. 
I recruited and collected data for the patients at Great Ormond Street 
Hospital. I maintained the database and sorted out any problems identified by 
the nurses at follow-up. I wrote regular newsletters as the trial progressed to 
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keep the involved clinical teams up-to-date and also to introduce the trial to 
new doctors rotating through the General Surgery and Interventional 
Radiology units. I wrote reports for the trial funding body and ethics 
committee. The trial was overseen by the trial steering committee and 
monitored by an independent data monitoring and ethics committee. 
2.4.10 Statistical Methods 
Data were entered into Microsoft Excel 2010 analysed using SPSS (Version 
22) and Stata InterCooled version 12. 
Data were analysed by Poisson (number of complications) or zero-inflated 
Poisson (complication score), with all the minimization criteria as covariates. 
Follow-up times were compared by a Mann-Whitney test. 
2.4.11 Data Monitoring and Interim Analysis  
Participants were allocated a unique study number, and all study data were 
stored with this number as the identifier. Identifiers were held in a separate 
database. Data was analysed at the Institute of Child Health. 
It was recommended to convene a Data Monitoring and Ethics Committee 
(DMEC), which would review the data when 100 patients had been recruited. 
The DMEC would be independent of both the trial organisers and those 
providing therapy. This committee would perform interim analyses to:  
a) review assumptions underlying sample size considerations;  
b) modify or close intake to trial.  
The criteria for stopping the trial were defined as:  
(i) a significant difference (p<0.01) between the two arms in overall 
complication rate; or  
(ii) significantly (p<0.01) greater incidence of major complications; in 
one arm compared to the other, analysed both as single outcomes 
and as total cumulative complications. 
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The Data Monitoring and Ethics Committee was convened on 25th September 
2013 (DMEC Report – Appendix 4). By this time 125 patients had been 
recruited into the trial, but for the purpose of interim analysis 100 patients 
were reviewed (as defined in the trial protocol, Appendix 1). The DMEC did 
not have any ethical concern and recommended to continue intake into the 
trial to complete the originally set out target of 200 patients. 
 
2.5 Results 
2.5.1 Participant flow 
The flowchart in Figure 2-2 demonstrates the flow of participants through each 
stage of the trial (assessment, enrolment and treatment) according to the 
CONSORT guidelines (Moher et al., 2010) for reporting. Three hundred and 
thirty-nine patients were assessed for eligibility and 214 were enrolled in the 
trial. One hundred and twenty-five patients were excluded from the trial 
(Table 2-3). Fifty-six patients were not eligible due to various reasons – 31 
did not meet the inclusion criteria, 11 did not need a gastrostomy any more, 6 
terminally ill patient required the gastrostomy as a part of palliative treatment, 
6 patients had complex neuro-muscular disorder and were following 
individualised treatment pathway which included PEG placement and 2 
patients had anaesthetic risk too great for procedure to be performed in the 
interventional radiology suite. Sixty-nine patients were eligible but not 
enrolled. Thirty patients declined to participate in the trial, 19 patients needed 
urgent gastrostomy and both PEG and RIG slot were not available so could 
not enter the trial, 18 patients were foreign resident, so unlikely to be able to 
complete the follow-up, 2 patients were under the child safeguarding team 
without designated parental responsibility. 
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Not meeting inclusion criteria 31 
No longer needed 11 
Palliative 6 
Complex patient, following Neuro-muscular pathway 6 
Complex anaesthetic issue, not suitable for IR suite 2 
Eligible but not enrolled 
Declined 30 
Urgent, no similar slot for PEG/RIG  19 
Foreign resident/no fixed abode 18 
Safeguarding issue, child in transitional care 2 
Total Eligible but not enrolled 69 
Total excluded after assessment 125 
Of the 214 randomized patients, 107 were allocated to each arm (PEG and 
RIG). Two patients randomized to RIG received a PEG. One patient, who 
had been randomised to RIG, had Treacher Collins Syndrome. At pre-
anaesthetic work-up it was realized that on previous anaesthetic for a 
microlaryngoscopy and bronchoscopy the patient had a difficult airway and 
had needed two senior anaesthetists. It was decided that for a patient with 
such an airway, it would be in his best interest to operate in the operating 
theatre suite which is better equipped for complex patients rather than the 
interventional radiology suite. He was therefore, re-scheduled to have a PEG 
after being randomized to RIG. Another patient, who had been randomised to 
RIG, had a PEG; as on the day of the operation a major incident in the 
interventional radiology suite meant that he was cancelled. However, a 
cancellation on the general surgery operating list resulted in him having a 
PEG on the same day. Available demographics and follow up for these 
patients are included in RIG dataset analysis on an intention to treat basis. 
Sixteen further patients did not receive their intervention, and five patients 
had no follow-up, as indicated in Figure 2-2, so that 97 patients were 
analysed for the primary outcome in the PEG group and 96 in the RIG group. 
  
Table 2-3 Characteristics of patients excluded after assessment 
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Figure 2-2 CONSORT diagram indicating patient flow through the trial 
 
CONSORT 2010 Flow Diagram 
 
 
 
 
 
 
 
 
 
Assessed for eligibility (n=339) 
Excluded  (n=125) 
• Not meeting inclusion criteria (n=31) 
• Declined to participate (n=30) 
• Other reasons (n=64) 
Received PEG (n=100) 
Converted to open, no further follow-up (n=1) 
Died before first follow-up (n=1) 
Lost to all follow-up (n=1) 
Analysed (n=97) 
 
Allocated to PEG (n=107) 
Received PEG (n=100) 
Did not receive PEG (n=7) 
• No longer needs gastrostomy (n=5) 
• Needed concurrent procedure (n=1) 
• Researcher unavailable (n=1) 
Received RIG (n=96), received PEG (n=2) 
Lost to follow-up (n=2) 
Analysed (n=96) 
Allocated to RIG (n=107) 
Received RIG (n=96) 
Did not receive RIG (n=11) 
• No longer needs gastrostomy (n=4) 
• Declined after allocation (n=3) 
• Researcher unavailable (n=1) 
• Died before RIG (n=1) 
• Received PEG (n=2) 
Allocation 
Follow-Up 
/Analysis 
Randomized (n=214) 
Enrollment 
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2.5.2 Recruitment 
Patients were recruited between November 2011 and November 2014 
(Figure 2-3). They were followed up at 6 weeks, 6 months, 1 year and 3 
years after procedure.  
 
 
Figure 2-3 Chronological progress of patient recruitment 
  
An independent data monitoring and ethics committee (DMEC) was 
convened and reviewed data on the first 100 patients recruited. The 
committee did not have any ethical concern and recommended to continue 
the intake into the trial to complete the target of 200 patients. After 36 months 
214 patients were recruited and 198 (100 PEG and 98 RIG) received their 
intervention. 
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2.5.3 Baseline data 
The 214 children enrolled were randomised to either PEG or RIG with 
minimisation using the SiMin® software. There were 100 PEG and 98 RIG for 
analysis. Patients in the two groups were well matched, with no significant 
differences in any of the demographic or clinical variables measured (Table 
2-4). For the purpose of analysis, the two patients who had been initially 
Criteria PEG RIG p* 
Diagnostic Group 
Neurological 32 29 0.76 
Haematology/Oncology 24 24 1 
Metabolic 12 13 0.83 
Gastrointestinal disease 1 2 0.62 
Miscellaneous 31 30 1 
Age 
<6months 6 5 1 
6months-2years 35 36 0.88 
2-5years 26 32 0.35 
>5years 33 25 0.28 
Weight centile 
<3% 35 34 1 
3-10% 18 16 0.85 
10-25% 11 12 0.83 
25-50% 15 15 1 
>50% 21 21 1 
Inpatient status 
Inpatient 9 9 
 Outpatient 91 89 1.00 
Scoliosis 
Yes 3 0 
 No 97 98 0.25 
Gastro-oesophageal reflux 
Yes-Not needing anti-reflux 
surgery 24 27 
 No 76 71 0.63 
 Group Totals 100 98 
 Table 2-4 Patient demographics and clinical characteristics 
*Chi2 test for independence 
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allocated to RIG, but had PEG due to anaesthetic and practical issues have 
been analysed as RIG on an intention to treat basis. There were only 1 PEG 
and 2 RIG patients with primary gastrointestinal disorder, as most of the 
children requiring a gastrostomy with a gastrointestinal disease were 
operated in the gastro suite. 
2.6 Primary Outcome Measure – Number of complications 
(major and minor) 
Follow-up was for median of 1 year (range 6 weeks to 3 years) in each 
group, and was similar between the groups (p=0.474). The number of 
patients in each group attending each follow-up is shown in Table 2-5. The 
total number of complications after PEG and RIG were as in Table 2-6. 
 PEG (n=97) RIG (n=96) 
6 weeks 91 94 
6 months 86 80 
1 year 69 68 
3 years 32 36 
Table 2-5 Number of patients attending each follow-up  
(In addition to patients failing to attend follow-up, and mortalities, other reasons for non-
follow up were gastrostomy removal or conversion to a balloon secured device). 
 PEG (n=97) RIG (n=96) Total 
Major 
Complications 
2 3 5 
Minor 
Complications 
79 78 157 
Table 2-6 Number of patients with complications after PEG/ RIG 
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Only five patients experienced a major complication, two in the PEG group (2%) 
and 3 in the RIG group (3%). The distribution of number of complications in 
each patients group is shown in Figure 2-4. 
 
Figure 2-4 Distribution of complications between PEG and RIG  
Factor Incidence rate ratio (95% CI) p-value 
RIG 0.98 (0.80 - 1.21) 0.875 
Age (per year increase) 0.99 (0.96 - 1.03) 0.700 
Haematological/Oncological 0.97 (0.70 - 1.34) 0.846 
Metabolic 1.19 (0.85 - 1.66) 0.303 
Gastrointestinal 1.06 (0.56 – 2.00) 0.864 
Miscellaneous 0.92 (0.70 - 1.20) 0.536 
Weight centile 1.00 (1.00 - 1.00) 0.601 
Inpatient 1.23 (0.79 – 1.91) 0.357 
Scoliosis 0.70 (0.17 – 2.85) 0.615 
Gastro-oesophageal reflux 1.24 (0.96 - 1.60) 0.105 
Table 2-7 Poisson regression analysis of total number of complications 
(major and minor)  
Adjusted for length of follow-up, and the minimization criteria. Incidence rate 
ratios are compared with a neurologically impaired four-year-old outpatient on the 
25th centile for weight, without reflux or scoliosis, having a PEG, in whom the total 
number of complications is 1.23 (95% CI 0.97 – 1.56). 
 
  PEG vs. RIG Trial 
 
64 
The number of complications per patient was analysed by standard Poisson 
regression, as this allows adjustment for different lengths of follow-up (Table 
2-7). A standard Poisson analysis was used rather than zero-inflated as the 
Vuong test indicated that zero-inflated Poisson was not a better fit to the data 
(p=0.5). A neurologic 4-year-old outpatient on the 25th centile for weight 
having a PEG, with neither reflux nor scoliosis was used as the reference 
patient to compare other variables. Compared with this reference patient, 
RIG patients had a similar rate of complications to PEG patients (0.98 [95% 
CI 0.80-1.21]-fold lower rate of complications, p=0.875). None of the 
minimization criteria showed a statistically or clinically significant effect on 
rate of complications. 
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2.7 Secondary Outcomes 
2.7.1 Major complication rate 
There were two patients with major complications in the PEG group. A 
neurologically impaired one-year old patient developed a buried bumper. It 
was discovered during routine replacement of the device being attempted in 
the Interventional Radiology suite, 2 years following insertion. The parents 
did have problems with leaking around the gastrostomy site for some time 
and had the end of the Freka tube replaced a few times before. She had the 
buried bumper removed endoscopically and replaced by another PEG. 
Another 5-year-old oncology patient had the gastrostomy tube passing 
through the liver, which was discovered incidentally on a CT scan after 3 
years. He is due for surgery to have this removed. 
There were three major complications after RIG, each requiring a general 
anaesthetic. A two years old girl with neurological impairment and feeding 
problems secondary to hypoxic ischaemic encephalopathy had a RIG 
inserted. She developed abdominal pain and discomfort post operatively. 
She was managed conservatively initially, however, 11 days later she 
needed a laparotomy. She had a gastro-colic fistula, which was closed and a 
new gastrostomy was fashioned. A two years old boy with epilepsy and 
learning disorder developed an abscess at the gastrostomy site in the 
immediate post-operative period. It was aspirated under a general 
anaesthetic. A five-year-old child with hyperinsulinism developed feeding 
difficulty with the gastrostomy and was discovered to have a buried bumper 
during tube replacement and needed a laparotomy and excision of 
inflammatory mass three years after the initial procedure. 
2.7.2 Minor complication rate 
The minor complications for the patients were as in Table 2-8. The minor 
complications included wound infection, discharge, granulation, tube-related 
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problems (such as migration, dislodgement, leakage, breakage) and delay of 
more than 48 hours in establishing feeds caused by abdominal 
pain/temperature/nausea. One hundred and eight children (56 PEG and 52 
RIG) had more than one minor complication. There was no significant 
difference between the two groups (p=1.00). 
 
Table 2-8 Minor Complications  
*Fisher’s exact test comparing proportion of patients having any minor complication 
2.7.3 Complication Score 
The distribution of complication scores in the two groups and the 
complication score per year of follow-up is shown by diagnostic group in 
Figure 2-5 (a and b). 
 PEG (n=97) RIG (n=96) 
Number of patients with minor 
complications  
79 78 
Number of minor complications  177 175 
p-value* 1.00 
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Figure 2-5 (a) Distribution of complication scores between PEG and RIG patients (b) 
Complication score per year of follow-up by diagnostic group. 
Three outliers are excluded from figure b: a score of 520/year in the miscellaneous group 
(gastro-colic fistula 10 days after procedure), 35/year in the haematology/oncology group, 
and 25/year in the neurology group. 
 
Although there were fewer patients (40/193) with a zero complication score, a 
Vuong test (which compares zero-inflated with a standard Poisson model) 
suggested that the zero-inflated model provides a better fit to the data 
(p=0.04). A neurologic 4-year-old outpatient on the 25th centile for weight 
having a PEG, with neither reflux nor scoliosis was used as the reference 
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patient to compare other variables. Compared with the reference patient, 
there was no statistically significant effect of having a RIG (1.04-fold higher 
complication score, p=0.597; Table 2-9). Although older patients had a 
statistically significant lower complication score (p=0.037), the magnitude of 
the effect (0.97 fold per year) was not great. 
  
Table 2-9 Zero-inflated Poisson regression analysis of complication score. 
Adjusted for length of follow-up and the minimization criteria. Incidence rate ratios are 
compared with a neurologically impaired four year old outpatient on the 25th centile for 
weight, without reflux or scoliosis, having a PEG, in whom there is a complication score of 
2.96 (95% CI 2.49 – 3.52), p<0.0005 
Factor Incidence rate ratios (95% CI) p-value 
RIG 1.04 (0.89 - 1.21) 0.597 
Age (per year increase) 0.97 (0.95 – 1.00)  0.037 
Haematological/Oncological 0.88 (0.69 – 1.13)  0.321 
Metabolic 0.86 (0.67 – 1.11)  0.254 
Gastrointestinal 1.45 (0.99 – 2.12)  0.055 
Miscellaneous 1.07 (0.88 - 1.31)  0.471 
Weight centile 1.00 (1.00 - 1.00) 0.566 
Inpatient 0.91 (0.63 - 1.32) 0.616 
Scoliosis 0.62 (0.19 – 1.99)  0.420 
Gastro-oesophageal reflux 1.05 (0.87 - 1.26)  0.597 
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2.7.4 Technical failure 
There were two RIG failures. The first was a child with spastic quadriparesis 
and epilepsy, being fed through a naso-gastric tube, who also had scoliosis. 
An attempt to insert a RIG failed. The operating radiologist could not safely 
position a gastrostomy into the stomach due to the altered anatomy as a 
result of previously unrecognised scoliosis. She later had a successful PEG 
placement. 
Another child with epilepsy and global developmental delay, who was fed via 
a naso-gastric tube, could not have a RIG. The operating radiologist could 
not find a safe window for placement of the gastrostomy.  He later had a 
successful PEG placement.  
There was one PEG failure. She was a child with Neuronal Ceroid 
lipofuscinosis (neurodevelopmental regression), infantile seizures and unsafe 
swallow. On attempted PEG placement, there was no recognisable light from 
the endoscope and the indent visible on endoscopy was immediately below 
the xiphisternum, which is not suitable for gastrostomy placement. The 
procedure was converted to open gastrostomy placement under the same 
anaesthetic.  
2.7.5 Cost of hospital treatment 
Although cost of hospital treatment was an outcome measure defined in the 
protocol, the hospital costing department were unable to provide reliable cost 
data on a per patient basis, so these data are not reported. 
2.7.6 Mortality 
Twenty-six patients died after a PEG/RIG insertion, all due to progression of 
their primary disease and none related to gastrostomy insertion or 
management. There was no significant difference between the two groups 
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(Table 2-10). One patient died within one month of gastrostomy insertion. It 
was reported as a Serious Adverse Event to the research and ethics 
committee (Appendix 5). The death resulted from severe and uncontrolled 
epileptic encephalopathy in a hospice. The ethics committee reviewed the 
death and concluded that it was not related to the intervention. 
 Survival Death ‘p’ value* 
PEG 84 16 0.29 
RIG 88 10 
 
2.7.7 Cause of death 
 In a number of children a gastrostomy insertion is a form of palliation. There 
were 6 children that were excluded from the trial as they were having the 
gastrostomy for ease of feed or administration of medications towards the 
end of their life, and that their inclusion in the trial was not justified. However, 
other children with life-limiting disorders died during the trial period. Most 
children who died had a haematological/oncological or immunosuppressive 
disorder or a life limiting inherited/metabolic disorder (Table 2-11). The 
deaths occurred 1-44 (median 13) months after the PEG/RIG insertion.
Table 2-10 Number of deaths in each group 
*Fisher’s exact test 
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Table 2-11 Cause of death and the underlying disease 
CMV = Cytomegalovirus, ALL = Acute Lymphoblastic Leukaemia, AML = Acute Myeloid 
Leukaemia, GvHD = Graft vs. Host Disease, VSD = Ventricular Septal Defect, ASD = Atrial Septal 
Defect, PDA = Patent Ductus Arteriosus, DOCK 8 = Dedicator of cytokinesis 8 
Patient 
Number 
Diagnosis - Cause of death  Months 
since 
PEG/RIG 
4 Congenital CMV, hydrocephalous, chronic liver disease 44 
9 Propionic Acidaemia - Failed liver transplant 25 
11 Medulloblastoma 7 
22 Low grade glioma 2 
25 Posterior fossa tumour 36 
51 Cardiac rhabdomyosarcoma 13 
54 Metastatic Medulloblastoma 13 
67 ALL 6 
77 Metastatic alveolar rhabdomyosarcoma 20 
85 Menke's disease, seizures, progressive neuropathy 5 
97 X linked chronic granulomatous disease 9 
98 AML 4 
102 Cartilage Hair Hypoplasia 9 
105 Epilepsy - Cardio respiratory arrest due to recurrent pulmonary 
haemorrhages 28 
108 Kearns-Sayre syndrome, hypomagnesemia hypocalcaemia, 
heart block, right sided ptosis & strabismus 24 
115 Primordial dwarfism, bilateral hip dysplasia - Respiratory arrest 12 
117 Glutaric Acidaemia Type 1 17 
119 Cerebral Palsy 26 
127 Infantile Pompe's disease 2 
136 Cerebellar hypoplasia 13 
138 Epileptic encephalopathy 1 
140 Leukodystrophy, dystonia 15 
141 AML - GvHD 22 
153 Relapse ALL 19 
161 Trisomy 21, Previous VSD, ASD, PDA repair 12 
204 DOCK 8 deficiency 7 
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2.8 Discussion 
Although a previous retrospective review from the same hospital had 
suggested that there was a significantly higher rate of complications following 
RIG than PEG (Nah et al., 2010), this was not confirmed by this prospective 
randomised controlled trial, in which I showed that there is no difference in 
outcomes or complications between insertion of PEG or RIG. There was no 
pre procedure difference between the groups, and post procedure there were 
no significant differences between PEG and RIG in any of the secondary 
outcome measures. This difference between the retrospective review and the 
randomised controlled trial is probably due to significant demographic 
differences between the PEG and RIG populations in the retrospective 
review. In particular, in the previous study RIG group consisted of 
predominantly patients with a haematological or oncological primary 
diagnosis, whereas the PEG group consisted predominantly of patients with 
a neurological primary diagnosis.  
The major complications observed during the trial, i.e. gastro-colic fistula, 
buried bumper and abscess requiring aspiration under a general anaesthetic 
are well recognised complications after a percutaneous gastrostomy 
placement (Schrag et al., 2007). A review of the literature (Table 2-12), 
suggests gastro-colic fistula to become apparent anywhere between 48 
hours (Khattak et al., 1998) to 29 months (Gauderer, 1991) after insertion of 
a percutaneous gastrostomy. Our retrospective review over 13 years 
revealed buried bumpers in 20 children between 1 month to 5 years post 
percutaneous gastrostomy insertion (Singh et al., 2013) (Chapter 3). Given 
these durations of appearance of the complications it can be argued that the 
maximum follow up of 3 years in the trial is not long enough to capture all the 
complications. A gastro-colic fistula may become apparent only when the 
initial Freka device is being changed to a balloon secured device, as a 
change to another Freka does not lead to disruption of the tract, while the 
new Freka device is guided in. A buried bumper can remain asymptomatic 
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and undiscovered until the device is being replaced (Cyrany et al., 2016, 
Singh et al., 2013). However, although the development of a gastro-colic 
fistula is related to over-inflation of the stomach and small intestine, pulling 
the colon cranially and thus inter-positioning it in between the anterior 
abdominal wall and the stomach; the development of a buried bumper is on 
the other hand as a result of inadequate post insertion gastrostomy care. As 
the incidence of gastro-colic fistula might differ between the two insertion 
techniques, any difference in the rate of gastro-colic fistula between the two 
arms of the trial should be apparent within the 3-year follow-up. Conversely, 
as buried bumper is more dependent on adequate care rather than the 
insertion technique, the rate of buried bumper incidence should not be used 
as a benchmark to compare outcomes between PEG and RIG. 
 Gastro-colic fistula timing 
post gastrostomy  
Median (range) in months 
Buried bumper timing 
post gastrostomy  
Median (range) in months 
Gauderer (1991) 5 (4-29)   
Beasley et al. (1995) Post mortem finding   
Khattak et al. (1998) 10.5 (48hrs-18m)  
Segal et al. (2001) 8 (5-12) 18 (4-41) 
Sathesh-Kumar et al. (2009) 17 24 
McSweeney et al. (2013)  3 
Singh et al. (2013)  30 (1-60) 
Table 2-12 Literature review of gastro-colic fistula and buried bumper post 
percutaneous gastrostomy insertion 
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In this era of minimally invasive surgery, laparoscopic assisted gastrostomy 
insertion is becoming the preferred technique with some surgeons. The 
primary advantage being the ability to visualise the external wall of the 
stomach inside the abdomen, decreasing the chances of inadvertent injury to 
the transverse colon or other intra-abdominal viscus. Insertion of PEG or RIG 
is contraindicated in patients with upper airway obstruction such as in head 
and neck malignancy or severe burns and oesophageal obstruction. In such 
patients laparoscopic assisted gastrostomy insertion may be preferred over 
open gastrostomy insertion (Mizrahi et al., 2014). However, laparoscopic 
gastrostomy insertion may be associated with a significant increase in costs 
(longer theatre time, instrumentation cost etc.) and introduces a potential for 
additional difficulties that are not considerations for either PEG or RIG (e.g. 
anaesthetic considerations of laparoscopy). At the outset of the trial, we did 
consider whether to undertake a trial comparing laparoscopy with both PEG 
and RIG, but as laparoscopic gastrostomy was infrequently performed in our 
hospital, the decision was made to compare the two procedures which were 
most frequently performed, i.e. PEG and RIG.  
In the trial we were successful in reaching the target number of patients, as 
per the power calculation. It was initially thought to be achievable in two 
years however; it took three years to reach the target. This was due to initial 
logistical problems. Subsequently, there was also significant delay due to 
lack of dedicated theatre time available for PEGs.  
In the trial we believe we achieved successful blinding of the parents and the 
assessors, although this was not formally tested. Even though, some parents 
were curious to know their allocation, they understood the nature of the trial 
and did not insist on knowing the allocation. Although when the child enters 
radiology suite or operating theatre complex, it should be very apparent 
which arm of the trial the child is in; either due to parental anxiety or faith in 
the trial procedure, parents were not aware of the group allocation. I 
acknowledge that this was not a flawless process and during the study 
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design phase, there was consideration of performing the procedure in one 
suite. However the inconvenience of moving the dedicated fluoroscopic 
equipment, screens and endoscope to one site and then restricting the 
routine day-to-day usage where considered impractical. Parents who were 
unhappy to be blinded did not participate in the trial (30 out of 339 patients 
assessed for inclusion in the trial). The patient and parents or guardian were 
blinded to the method of gastrostomy insertion used. To ensure the blinding 
of the patients and assessors, I used a standard information sheet and 
consent form. The operation note was placed in a sealed envelope in the 
clinical notes. The post-operative gastrostomy wound for either PEG or RIG 
was dressed similarly. 
The research nurses assessing the outcomes (complications) were also 
blinded. For the assessment at follow-up of the patients, I organised training 
of the research nurses at the Somers Clinical Research Facility in Great 
Ormond Street Hospital. The nurses had no access to the patients’ clinical 
notes. I also designed a standard follow-up questionnaire to aid this 
(Appendix 3). The research nurses, who were assessing the outcomes, 
therefore were successfully blinded. 
This cohort of patients with similar characteristics will enable us to do future 
follow up. The information achievable from this prospectively collated patient 
population will help answer questions related to the natural history of their 
disease and also the widely assumed notion that the insertion of a 
gastrostomy worsens gastro-oesophageal reflux (Thomson et al., 2011). 
Gastro-oesophageal reflux was not assessed objectively using pH-
impedence study when the patients were enrolled into the trial. The inclusion 
into group with or without gastro-oesophageal reflux was made subjectively 
by the clinician assessing the child’s symptoms and reflux management. 
A preliminary analysis of the patients who had medically managed gastro 
oesophageal reflux at enrolment into the trial is as follows: 
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51 patients had documented gastro oesophageal reflux, i.e. 26% of all 
patients undergoing either PEG or RIG. Follow up of all these patients at a 
median of 3 years (2-4 years) after gastrostomy insertion showed that 8/51 
(16%) of the patients with gastro oesophageal reflux had worsening of their 
symptoms necessitating either anti-reflux operation (n=3) or a gastro- jejunal 
feeding (n=5). There is a statistically significant difference in the requirement 
for further procedure between the PEG and RIG groups (Table 2-13). It is 
difficult to understand why a RIG patient might be less likely to have 
worsening reflux. One possibility is that the PEG patients would have had a 
routine clinical surgical follow-up and the surgeon might have had a bias 
towards an anti-reflux procedure, whereas the RIG patient routine clinical 
follow-up would have been by the paediatric speciality who might have had a 
higher threshold to referring to a surgeon for an anti-reflux procedure and 
would have been more likely to persist with medical therapy. This is very 
much a post-hoc analysis as requirement for anti-reflux procedure was not 
defined as an outcome measure in the protocol and the indications for 
performing an anti-reflux procedure were not defined. Nevertheless, this is an 
important issue for which longer-term follow-up is important to examine 
evolution of these patients with gastro-oesophageal reflux. 
A formal cost analysis of the two procedures was unfortunately not 
undertaken as the hospital costings department were unable to provide data 
Table 2-13 Follow up of patients with pre-existing gastro-oesophageal reflux 
*Fisher’s exact test 
 
 No further 
procedure 
Gastro-jejunal tube / 
anti-reflux surgery 
Total  
PEG 18 7 25  
RIG 25 1 26 p = 0.02 * 
Total 43 8 51  
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suitable for a comparative analysis. In addition, such a comparison would be 
difficult because of the multiple co-morbidities present in many of the 
patients. However considering that both procedures would have a general 
anaesthetic and single night post-procedure hospital stay (for patients 
admitted for the procedure), the difference in cost would be down to the 
equipment used. In the case of PEG, this would be the cost of endoscopy 
and relative cost of time in the operating theatre versus interventional 
radiology suite and in the case of RIG, ultrasound, contrast medium and X-
rays.  
One weakness of the trial was difficulty in comparison of the complications in 
the two groups. Although we developed and used a complication scoring 
system specific for gastrostomy, a more generalisable scoring system 
specific for, and validated in, the paediatric population is much needed. Older 
patients had a significantly lower rate of complications, however the 
magnitude of the effect (0.97 fold per year) was not great. This was similar to 
our previous retrospective review (Nah et al., 2010) and has been shown in 
other studies (Goldberg et al., 2010). Our retrospective review (Nah et al., 
2010) suggested a higher complication rate in patients with higher weight z 
scores, however we did not detect this difference. In the current prospective 
trial, we found no difference in the rate of complications in 
haematology/oncology patients as compared to neurological patients, which 
is contrary to our findings in the retrospective review (Nah et al., 2010). 
Haematology/oncology patients might be expected to have a higher rate of 
infective complications and complications related to wound healing, because 
of immunosuppressive drugs. However, these complications only achieve a 
low score, whereas complications requiring further procedures and/or 
anaesthetics are assigned a higher score. No patient in the 
haematology/oncology group had a major complication, whereas major 
complications were observed in the neurological, gastrointestinal and 
miscellaneous groups. Conversely, haematology/oncology patients are less 
likely to have disordered gastric function when compared with the neurologic 
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patients in whom limited stomach compliance affects tolerated feed volume 
and leakage back along the gastrostomy tract.   
Technical failures occurred during the trial; there were two RIG failures 
necessitating a PEG, and one PEG failure necessitating an open 
gastrostomy. This is a potential disadvantage to the RIG, in that technical 
failure would require rebooking a theatre slot and a second general 
anaesthetic, whereas failure of a PEG can be converted to an open 
procedure under the same anaesthetic. RIG necessitates a radiation dose, 
with a dose-area product <0.1 µGy m2 for patients <15 kg, and <0.2 µGy m2 
for patients 15-30 kg. Technical failure was considered as a separate 
outcome in the protocol, so we have not considered these as complications. 
It would therefore be accurate to describe the trial outcomes as post-
operative complications to reflect this issue.  
Although the trial was powered to detect the total number of patients 
experiencing complications, on the basis of our own retrospective review 
(Nah et al., 2010), we also acknowledge that the trial was under-powered to 
detect a significant difference in incidence of any individual complication, 
such as gastro-colic fistula. The trial was designed to compare the incidence 
of complications, however, there may be other factors influencing the 
decision of whether to perform a PEG or a RIG, e.g. availability of procedure 
slots/ surgeons/ radiologist, relative cost of procedure etc. The finding of no 
significant difference in complications between the procedures allows 
decisions to be made on these other factors without compromising results. 
There is a limited literature on RIG in children; a recent systematic review 
and meta-analysis of gastrostomy placement in children (Baker et al., 2015) 
identified only our own retrospective review (Nah et al., 2010). We believe 
that the findings from our study are applicable to other centres with a 
paediatric interventional radiology service. Although many patients in each 
group experienced complications, most of these are minor complications and 
we believe that the benefits of insertion of a secured gastrostomy for long-
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term use outweigh the risks of repeated aspiration and/or accidental tube 
removal and replacement if a nasogastric tube were to be used for an 
extended period of time. As our retrospective review suggested a significantly 
higher rate of complications in the RIG group, we designed the study as a 
superiority trial. In order to determine equal effectiveness, it would have been 
necessary to perform a non-inferiority trial with a suitable definition of non-
inferiority trial. Nevertheless, major complications were rare in both PEG and 
RIG and so we feel that both procedures are clinically safe. RIG gave a 0.98 
(95% CI 0.80-1.21)-fold lower rate of complications, and a 1.04 (0.89-1.21)-
fold higher complication score rate than PEG, so there is no evidence from 
this trial that PEG is superior to RIG. 
2.9 Conclusions 
In conclusion, in patients for whom a percutaneous gastrostomy is 
appropriate, there is no evidence that either PEG or RIG leads to a 
significantly higher number of complications or complication score, which is 
contrary to a previous retrospective review. This indicates the importance of, 
when possible, undertaking prospective studies or RCTs to verify the 
conclusions from retrospective series in which differences are found. Further 
follow-up of these patients will indicate whether the equal efficacies of these 
procedures are still apparent at a later date. 
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3.1 Background 
Buried bumper is a rare but major complication after insertion of a 
gastrostomy. The internal bumper or flange migrates along the gastrostomy 
tract out of the stomach. The flange can lie anywhere between the stomach 
mucosa and the surface of the skin (Figure 3-1) 
This can be attributed to excessive tension between the external bolster and 
the internal bumper of the gastrostomy device causing pressure necrosis of 
the tissue in between (DeLegge et al., 2006). The gastrostomy tract evolves 
into an abscess cavity with infiltrate surrounding the migrating disc. The 
gastric mucosa covers the internal surface of the flange of the gastrostomy 
tube, therefore, giving rise to symptoms such as resistance upon infusing 
feeds, pain and peri-tubular leakage. The incidence has been reported to be 
1.3 to 21.8% in the paediatric population (Sathesh-Kumar et al., 2009, 
Furlano et al., 2008, Kohler et al., 2008, Binnebosel et al., 2010, Hodges et 
al., 2001, Segal et al., 2001). I reviewed the incidence and management of 
 
Figure 3-1(a) Correct position of a percutaneous gastrostomy (PEG) (b) Buried 
bumper 
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buried bumpers over 12 years. 
 
3.2 Patients and methods 
I obtained institutional ethical approval. I analysed the surgical and 
interventional radiology database from August 1999 to May 2011. I reviewed 
the records for children with buried bumper. I collected the demographic 
information, clinical diagnosis, symptoms at presentation, age at time of 
procedure, date of procedure, operative details, early and delayed 
complications, and length of follow-up. The percutaneous gastrostomy 
inserted in all cases was a 9 French silicone gastrostomy tube (Freka, 
Fresenius, Runcorn, UK). I conducted a telephonic interview with the parents 
of these children with focussed assessment of the care of the gastrostomy 
tube prior to the episode of buried bumper.  
3.3 Results 
Patient 
number 
Age (years) 
Time since 
gastrostomy (years) 
 
Removal by 
1 7 5 Interventional Radiology 
2 3 2 Laparoscopy 
3 4.5 0.58 Laparotomy 
4 9.25 0.5 Laparotomy 
5 3.75 2.5 Laparoscopy 
6 4.75 3.42 Laparoscopy 
7 15.2 2.5 Endoscopic 
8 5.25 3.92 Laparotomy 
9 12 2.1 Laparotomy 
10 4.75 3.5 Endoscopy 
11 12 3.25 Endoscopy 
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Patient 
number 
Age (years) 
Time since 
gastrostomy (years) 
 
Removal by 
12 18 3 Laparotomy 
13 5.83 2.83 Laparotomy 
14 2.83 1 Endoscopy 
15 9.25 1.25 Laparotomy 
16 4 1.42 Laparotomy 
17 3.25 0.75 Laparotomy 
18 7 3 Laparotomy 
19 12.34 0.08 Laparotomy 
20 5.6 3.84 Laparotomy 
 
There were 2,007 patients who underwent percutaneous gastrostomy 
insertion. Over the time period twenty children (11 boys) were found to have 
Table 3-1 Patient’s age, time since gastrostomy and method of removal 
Figure 3-2 Management of buried bumpers 
Buried Bumpers 
 
84 
a buried gastrostomy. Six children had a Freka gastrostomy with jejunal 
extension. Most of them (n=14) had underlying neurological condition. Three 
had a metabolic disorder and three, an endocrine disorder.  
The median age at presentation was 5.75 years (2.83 - 18 years). They 
presented at a median of 2.5 years (1 month - 5 years) after gastrostomy 
insertion (Table 3-1). Half of the children (n=10) presented with symptoms 
related to buried bumper which included leakage around the gastrostomy 
(n=4), pus, discharge or bleeding from the site (n=5), stiffness on feeding 
(n=3) and unable to push the flange (n=1). There were 3 children with more 
than one symptom. The other half (n=10) were asymptomatic and were 
booked for routine change or removal of gastrostomy. In nine children there 
was an attempt to remove the flange by interventional radiology but this was 
successful only in one. A snare was inserted through the catheter hole, under 
fluoroscopic guidance and the bumper was removed through the oesophagus 
(Turner and Deakin, 2009). In the remaining 19 children, 4 had endoscopic 
removal while 15 children developed an inflammatory mass and required a 
laparotomy (n= 12) or laparoscopic assisted excision (n= 3) (Figure 3-2). The 
four endoscopic removals included two removed by external traction against 
the abdominal wall. In the remaining two the flange was removed by pushing 
it from the wall of the stomach towards the lumen. To facilitate this, a metal 
probe was inserted into the shortened gastrostomy tube from outside, 
stiffening it and allowing the flange to be pushed into the gastric lumen 
(Figure 3-3). This was then retrieved by a snare; thus avoiding an open 
procedure. 
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Figure 3-3 A metal probe inserted into the shortened gastrostomy tube from outside 
The patients were followed up for 12 months (1-45 months). There were two 
complications (10%). One had a gastrostomy site infection and another an 
abscess of the old gastrostomy site, each needing oral antibiotics.  
3.4 Discussion 
Buried bumper has been described in the adult literature to potentially cause 
perforation of the stomach, peritonitis and death (Anagnostopoulos et al., 
2003). The commoner presenting symptoms of difficulty in infusing feeds, 
pain and peri-tubular leak might not be picked up initially, especially in the 
neurologically impaired child with difficult communication. 
The true incidence of buried bumper cannot be estimated by this study. This 
was a retrospective study and often the patients would go back to heir local 
hospital for follow up. In case of emergency presentation due to the buried 
bumper they could be taken to their local paediatric surgery hospital. 
Therefore, data for the true incidence of buried bumpers could not be 
captured. Even when the patients came back for follow up in our hospital, 
they did not undergo planned endoscopy and change to a balloon 
gastrostomy device at the recommended 3 months post gastrostomy tube 
insertion (Heuschkel et al., 2015).  
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The diagnosis can be made by the history and occasional palpation of the 
gastrostomy flange below the skin, with or without pain (Khalil et al., 2010). 
However, in our series palpation did not reveal the buried bumper, which was 
retained in the stomach wall. Radiological investigations such as ultrasound 
or computerized tomography can be useful (Hodges et al., 2001, Khalil et al., 
2010). However, the confirmation is made by endoscopy, which shows a 
mound of gastric mucosa, with minimal or absent visible gastrostomy disc.   
The two most widely used gastrostomy devices in the UK are Freka and 
Corflo gastrostomy. A recent study attributes the hard, thin internal bumper of 
Freka gastrostomy to predispose to buried bumper. In comparison their 
experience with the Corflo gastrostomy tube which has a thicker, cushioned 
internal bumper showed less incidence of buried bumpers (Dowman et al., 
2015) Figure 3-4. There are studies which associate this complication with a 
rigid or semi-rigid internal fixation device and rarely to a balloon secured 
device (Kim et al., 2006, Lee and Lin, 2008). Conversely, there has been 
Figure 3-4 Corflo and Freka percutaneous endoscopic gastrostomy (PEG) tubes. 
 The inner bumper on the Corflo (purple) PEG tube (A) is thicker and spongier 
compared with the thin and flat Freka (blue) inner bumper (B) 
Reprinted with permission from BMJ Publishing Group Ltd. 
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report of a buried gastrostomy balloon device (Smith and Goday, 2008). 
There are gastroenterologists and surgeons who believe in inserting a 
balloon device rather than a device with an internal bumper to avoid this 
complication. However a primary balloon secured device has a high risk of 
causing severe morbidity and possible mortality if the balloon gives way and 
the stomach separates from the anterior abdominal wall in the first few 
months post insertion, before the gastrostomy tract has formed and matured. 
Factors implicated in the development of buried bumper are excessive 
tension between the inner and outer flange of the gastrostomy, causing 
pressure necrosis of the gastric mucosa, leading to its migration into the 
abdominal wall and inadequate gastrostomy care (Hodges et al., 2001, Khalil 
et al., 2010).  
In a telephonic interview 15 (75%) parents /carers were not pushing the 
gastrostomy tube and rotating it, as is our present recommendation. Four 
parents could not be contacted and unfortunately, one child had died due to 
advanced primary disease. The NICE (National Institute for Health and 
Clinical Excellence) guideline for gastrostomy care in adults recommends 
weekly tube rotation to prevent internal over-granulation or buried bumper 
syndrome (2006). In children, the rotation of the tube should be associated 
with advancement of the flange at least once a week to avoid migration of the 
bumper into the wall of the stomach, as the child grows. There is increased 
incidence of buried bumpers in children with PEG with jejunal extension 
(Goring et al., 2016, Stewart et al., 2017). Although the device cannot be 
rotated, it should be advanced into the stomach.  
Various approaches have been suggested for the removal of the buried 
bumper. These include external traction, endoscopic, laparotomy, 
radiological-guided and laparoscopic excision (Khalil et al., 2010, Ehsan et 
al., 2012, Furlano et al., 2008, Kohler et al., 2008, Binnebosel et al., 2010, 
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Hodges et al., 2001, Segal et al., 2001, Turner and Deakin, 2009). In the 
suitable patient endoscopic submucosal dissection using HybridKnife (Curcio 
et al., 2014) or single-step endoscopic procedure using an 18-mm 
oesophageal balloon dilator to extract the bumper through the stomach and 
mouth can be used (Christiaens et al., 2014). Our experience in an 
uncomplicated buried bumper i.e. without an inflammatory mass favours 
endoscopic-guided removal. In children with an inflammatory mass, 
laparoscopic-assisted excision facilitates dissection, minimises tissue 
disruption and should be the first choice. Radiological-guided removal of a 
buried gastrostomy in children is rarely successful and requires an 
experienced interventional radiologist. 
3.5 Conclusions 
Buried bumper is an uncommon, serious complication of one of the 
commonest procedures in children. This can be avoided by proper 
gastrostomy care. Endoscopic removal should be the first line of treatment, 
failing which a laparoscopic assisted excision or laparotomy is 
recommended. 
3.6 Recommendations 
It is advised that a prospective registry is maintained to keep track of all 
gastrostomy tube inserted. They should be assessed by at least 3 months 
post insertion and a plan to either change to a balloon secured gastrostomy 
device or removal be made with the parents/carers. The morbidity associated 
with a buried bumper is great and if the underlying medical condition 
prevents this, then the child should have an endoscopy and change of the 
device no later than 2 years after insertion of the gastrostomy tube. 
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4.1 Background 
In children with gastrointestinal dysfunction, jejunal access can be used for 
enteral feeding. The inability to tolerate gastric feeding can be due to 
gastro-oesophageal reflux, gastric dysmotility and poor gastric compliance 
(Raval and Phillips, 2006). Historically, these children received a surgical 
jejunostomy (SJ). Radiologically inserted gastro jejunal tubes (RGJ) are now 
more commonly used than surgical jejunostomy (Hoffer et al., 1999, Wales 
et al., 2002).  
I reviewed outcomes in children with surgical feeding jejunostomy and 
radiologically inserted trans-gastric jejunal feeding tubes at my institute.  
4.2 Methods 
After appropriate institutional audit approval (no. 1035), a retrospective 
review to identify patients who had a jejunostomy in the year 2010 was 
performed. I reviewed the hospital coding database and identified seventy-
eight children who had a jejunostomy in 2010. Of these, 29 children were 
excluded as detailed notes review revealed that they either did not have the 
primary jejunostomy in 2010 or the jejunostomy was a part of laparotomy to 
act as a de-functioning stoma. I extracted data on outcomes from those with 
a ‘de novo’ RGJ or SJ from clinic and discharge letters, admission records, 
imaging procedures and inpatient stay records. Procedures were performed 
by consultant interventional radiologists or paediatric surgeons; or by 
trainees at specialist registrar level under direct supervision of a consultant.  
I compared RGJ and SJ patients with respect to demographic data, 
neurological diagnosis, indication, previous anti-reflux surgery, 
complications, hospital admission, further surgery, removal of the device 
and follow up. I reviewed their weights before and after RGJ or SJ as an 
outcome measure. Weight-for-age Z scores (Standard deviation scores) 
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were calculated using the LMS growth add-in (Cole and Pan, 2011) for 
Microsoft Excel 2010 (Microsoft Corporation) program, using British 1990 
reference data (Cole et al., 1998). A Z-score of 0 is equivalent to 50th 
centile, -1 to 16th centile and -2 to 2nd centile. Malnourished children were 
defined weight Z-score of -2 or less. Growth over time was assessed as 
mean change in Z-score per year by Multilevel modelling using MlWin 2.36 
(Centre for Multilevel Modelling, University of Bristol, Bristol, UK).  
4.3 Results 
Forty-eight children had access for jejunal for feeding in the year 2010 and 
they were included in the study. Demographic data are presented in Table 
4-1. More than half of the patients who received either RGJ or SJ were 
Table 4-1 Demographic data of children receiving a jejunostomy in 2010.  
 RGJ (n=36) SJ (n=12) 
Age median 
(range) in months 
37 (5-202) 41 (6-213) 
Sex 17 males/ 19 females 11 males/ 1 female 
Neurological 
impairment 
21 (58%) 8 (67%) 
Other indications - 
Gastric dysmotility 
associated with: 
 
Metabolic disorder 3 
Oesophageal atresia 2 
Failure to thrive 2 
Cardiac disorder 2 
Malignant disorder 2 
Endocrine disorder 1  
Dystrophic epidermolysis bullosa 1 
Short bowel syndrome after resection  
   for multiple atresia 1 
Severe combined immune deficiency 1 
Oesophageal atresia 1 
Gut failure due to immune     
   dysregulation 1 
Metabolic disorder 1 
Endocrine disorder 1 
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neurologically impaired (58% and 67% respectively). Indications for jejunal 
feeding are listed in Table 4-2 In 83% of SJ and 69% of RGJ it was 
recurrent gastro-oesophageal reflux. This was confirmed by either a 
contrast study, or pH study. The majority of children in each group had a 
previous anti- reflux operation n=19/36 (53%) in RGJ and n=612 (50%) in 
SJ (Table 4-3). 
 
 RGJ (n=36) SJ (n=12) 
Recurrent GOR 25(69%) 10(83%) 
Not tolerating gastric feeds 11(31%) 0 
Duodenal obstruction due to: 
Multiple intestinal strictures 
 
0 
 
1(8%) 
Long gap Oesophageal atresia: 
Gastric pull up + SJ 
 
0 
 
1(8%) 
Table 4-2 Indications for jejunal feeding 
GOR = Gastro-oesophageal reflux  
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The type of surgical jejunostomy depended on the choice of the operating 
surgeon and the disease aetiology. Most of the surgeons preferred 
formation of Roux-en-Y jejunostomy (Table 4-4). 
 
 
 
 RGJ (n=36) SJ (n=12) 
Previous 
surgery 
n (%) 
Fundoplication +G                  15 (42) 
Gastrostomy                           12 (33) 
Fundoplication + Revision + G  4 (11) 
None                                         5 (14) 
Fundoplication + G                        5 (42) 
Gastrojejunostomy                        4 (33) 
Laparotomy                                   3 (25) 
Gastrostomy                                  3 (25) 
Fundoplication + Revision twice+G 1 (8) 
None                                                1 (8) 
 (n=4 had more than 1 procedure) 
Further 
surgery 
n (%) 
Revision Fundoplication + G    6 (17) 
SJ                                             4 (11) 
Removal of buried bumper       3 (8) 
Fundoplication + G                   2 (6) 
Revision of G                            3 (8)  
 (n=3 had more than 1 procedure) 
Re-fashioning                                2 (17) 
Laparotomy (bowel obstruction)    2 (17) 
 
Table 4-3 Previous surgery and further surgery after a RGJ or SJ  
G = gastrostomy 
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Type of SJ : 
Roux-en-Y n=7 
Witzel tunnel n=4 
Laparoscopy-assisted n=1 
There were 4 major complications in each of the RGJ (11%) and SJ (33%) 
groups (Table 4-5). 
Complications (n=8) 
RGJ (n=4) Buried bumper  
SJ (n=4) 
 
Bowel obstruction 
(n=2) 
Colon volvulus and 
ventral hernia at 
fundoplication site  (roux-
en-Y SJ, n=1) 
Intussusception and 
small bowel volvulus 
(tunnel SJ, n=1) 
Re-fashioning of SJ due to stenosis/atresia 
(n=2) 
 
The RGJ group needed tube replacement 1.3 (0-20) times/year. Fifteen 
needed further operation (Table 4-3). In 20/36 children, RGJ was removed 
after 0.8 years (0.1-2.4). Four were fed orally, 3 oral with gastrostomy, 5 via 
gastrostomy alone, 5 had fundoplication plus gastrostomy and 3 converted 
to SJ. 
Table 4-4 Type of surgical jejunostomy. 
Table 4-5 Complications after RGJ and SJ. 
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Twelve children had SJ (Table 4-4), which was a part of laparotomy in 5/12. 
Four (33%) had SJ after RGJ. SJ was reversed in one orally fed child. 
Nutritional outcome was measured as weight Z-scores over time. RGJ 
children were on average slightly underweight (mean -1.4 ± standard error 
0.26 Z-scores) at jejunostomy, with 4/36 (11%) of children malnourished 
(less than -2 Z-scores) SJ children were on average significantly 
malnourished (-3.7±0.99 Z-scores) at the time of jejunostomy, with 4/12 
(33%) of children less than -2 Z-scores. RGJ children grew stably (+0.4±0.1 
Z-scores per year FU, p=0.58) and growth significantly improved following 
SJ (+1.2±0.3 Z-scores/year FU, p<0.0001) (Figure 4-1 and Figure 4-2). 
RGJ were followed up for a median of 2.4 (0.18-3.4) years, while SJ were 
followed up for a median of 1.8 (0-3.5) years.  
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Figure 4-1 Weight Z scores for children after SJ.  
Individual patients are shown together with the mean trend line with 95% confidence 
intervals of the mean, analysed by multilevel modelling. 
 
Figure 4-2 Weight Z scores for children after RGJ.  
Individual patients are shown together with the mean trend line with 95% confidence 
intervals of the mean, analysed by multilevel modelling. 
Jejunal feeding review 
 
97 
4.4 Discussion 
Following the PEG vs. RIG trial the next logical step would be to compare 
RGJ and percutaneous endoscopic gastrojejunostomies. However, 
percutaneous endoscopic gastrojejunostomies were not performed at my 
institution.  
Complex, neurologically impaired children have a range of feeding 
difficulties from uncoordinated swallow to GORD and gastrointestinal 
dysmotility. Once maximal medical therapy has failed management options 
include gastric tube feeding, anti-reflux procedure, jejunal feeding or a 
combination. The rate of recurrent GORD after an anti-reflux procedure is 
between 10-14% (Lopez-Fernandez et al., 2014, Rossi et al., 2016, 
Wheatley et al., 1991). For these patients a re-do fundoplication has a high 
failure rate of 20-30% (Kimber et al., 1998, Furnee et al., 2008). 
Jejunostomy feeding has been previously reported and may be preferred 
over a redo fundoplication (Albanese et al., 1993, Wales et al., 2002). Long 
term outcomes following SJ and RGJ have been compared in a previous 
series (Raval and Phillips, 2006). They concluded that SJ are more stable 
feeding access devices with fewer complications. 
There is a reported association of buried bumpers and gastro-jejunal tubes 
(Goring et al., 2016) (when the gastric component of the tube is inserted as 
a percutaneous technique). This can be due to reluctance of the carer to 
advance the gastro-jejunal device, for fear of dislodging the jejunal 
component. Due to presence of the jejunal tube the carers are advised to 
only advance the gastrostomy tube and not to rotate it. Often the jejunal 
component of the RGJ is routinely replaced and the gastrostomy device 
remains in situ for a longer duration than intended. 
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The children who received a SJ had various rare disease pathologies. One 
child had multiple intestinal abscesses as a part of global immune 
deficiency. He had multiple resections and anastomoses of the small bowel 
during formation of SJ. There was stenosis of the jejunostomy later as a 
part of the disease process and it required revision. Another child with 
congenital myopathy and oesophageal stricture, developed stenosis of the 
stoma mouth and needed re-fashioning of the jejunostomy. There were two 
children who developed small bowel obstruction due to adhesions (Table 
4-5). 
SJ have been reported to have a high complication rate (Table 1-2). 
Williams et al reported major complication rate of 37% (Williams et al., 
2007) and Smith et al reported a major complication rate of 31% (Smith and 
Soucy, 1996) with roux-en-Y SJ. Taylor et al reported volvulus around roux-
en-Y SJ in 5 out of 25 patients (20 % complication rate) (Taylor and 
Ryckman, 2010). Egnell et al reported 33% re-operation rate after SJ for 
small bowel obstruction, perforation, wound rupture tube dislodgement and 
tube leak (Egnell et al., 2014). At my institute the surgical technique has 
evolved over time, with roux-en-Y SJ, having a shorter stem of the roux-en-
Y limb, thus minimizing the risk of volvulus. 
Determining nutritional benefit from RGJ or SJ in this complex group of 
children is challenging. The use of weight Z-scores before and after the 
jejunostomy insertion gives an objective measure of the probable effect of 
the intervention on nutrition. As the underlying disease progresses, 
becomes stable or regresses, there may be an effect on absorption of 
nutrients from the gut and maintenance of nutrition. Changes in z scores are 
multi factorial and includes changes in feeding regime, formulas used, and 
other background general illness. The patients who had an RGJ were 
slightly underweight at the start and maintained stable weight gain 
(manifested as stable Z-score). The patients who had a SJ on the other 
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hand were significantly malnourished at SJ insertion and their growth 
improved significantly (significant increase in weight Z-score). Rather than 
just the effect of the jejunostomy this result reflects the fact that patients 
who had a SJ had the jejunostomy after progressive deterioration of the 
primary disease and failure of escalating nutritional interventions. Given our 
data, we conclude that both RGJ and SJ are effective as they have a 
stabilizing effect on reliable delivery of nutrition. 
Another aspect that requires consideration in the choice of procedure to be 
offered is the radiation dose received, not just at the initial RGJ insertion, 
but also each time the tube is replaced. In a sample of 110 consecutive 
patients (not the same patients as the primary study population, as data 
were not available) the median radiation dose-area product (DAP) for a 
change of RGJ tube was 7 μGy·m2 (0-622 μGy·m2, Figure 4-3) with a 
median fluoroscopy time of 25 s (0s-40min). There is no clear consensus 
regarding the additional cumulative lifetime risk of radiation to patients 
(Andronikou, 2017). 
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Figure 4-3 Dose area product (DAP) for 110 children having an RGJ tube change  
Horizontal line denotes the median DAP 
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The average cost of insertion of a SJ is around £11,000 as the procedure 
involves a general anaesthetic, theatre time and in patient stay of several 
days (although several SJ patients had SJ insertion together with another 
abdominal procedure), whereas the average cost associated with a day 
case admission and insertion of RGJ in the radiology suite is around £590 
(data obtained from the hospital costings department). The recurrent costs 
associated with each is also likely to be different: RGJ will require changing 
in IR approximately every 6 months, whereas the SJ tube can be replaced 
in an outpatient appointment. A full cost-effectiveness analysis, including 
the cost of complications, however was not undertaken as part of the 
current study. 
In the adults laparoscopic jejunostomy has been reported in 299 patients 
with low rate of post-operative small bowel obstruction (Young et al., 2016). 
Laparoscopic roux-en-Y jejunostomy has been reported in 5 children one of 
whom required dilatation for stomal stenosis (Neuman and Phillips, 2005). 
Esposito et al have described laparoscopic assisted jejunostomy formation 
in ten neurologically impaired children (Esposito et al., 2013). One patient 
(10%) died one year after the procedure of unknown causes. The other 
complications were four (40%) peristomal hernias, two (20%) device 
dislocation and 1 peristomal granuloma. 
Direct percutaneous endoscopic jejunostomy has been reported in five 
children with good results (Virnig et al., 2008). However in a large series of 
286 adult patients, the success rate was 68% and the procedure was 
associated with a complication rate of 10% (Maple et al., 2005). Recently 
percutaneous laparoscopic endoscopic jejunostomy has been reported in 
sixteen children (Belsha et al., 2016). They had two complications (12.5%) 
of small bowel volvulus, which required surgical intervention. 
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The effect of repeated hospital admission for RGJ tube replacement with 
inadvertent displacement on the quality of life of the patient and caregivers 
has not been studied in the adult or paediatric literature. However, we 
believe that this remains an important factor in their overall care.   
Although there are papers citing increased morbidity after a RGJ (Fortunato 
et al., 2005, Godbole et al., 2002), this remains a feasible alternative in the 
fragile patient with compromised respiratory function due to recurrent 
aspiration (Karabulut et al., 2015). 
4.5 Conclusions 
It is not intended to directly compare SJ and RGJ, as this group of patients 
represent a heterogeneous population who often have had a trial of 
nasogastric, gastric, naso-jejunal, RGJ feeding before becoming 
significantly malnourished, thus resorting to a SJ as a rescue procedure. 
Although RGJ require more device maintenance than SJ, they have less 
severe complications. RGJ can be used as a temporary stabilizing measure 
after failed anti-reflux operations in the neurologically impaired. Insertion or 
replacement through an existing gastrostomy under radiological guidance 
obviates the need for a general anaesthetic in most cases. The 
complications after a SJ although less, can be life threatening and may 
require an emergency laparotomy under a general anaesthetic. SJ is a 
definitive long-term feeding device.  
A consistently high DAP for tube changes in an individual patient might be a 
relative indication to convert from a RGJ strategy to SJ. The cost and 
inconvenience associated with tube replacement and hospital admission is 
another important consideration. This information should be presented to 
the family while counselling for the choice of jejunal tube. They should be 
able to make an informed decision along with the clinician. 
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RGJ and SJ are important tools for nutritional management that achieve 
and maintain growth in a complex group of children. The risk and benefits 
should be reviewed for each individual patient. 
4.6 Recommendations 
A well designed prospective randomised controlled trial, with a sample size 
to detect a difference in complications/outcomes after anti-reflux operation 
or gastro-jejunal tube feeding in neurologically impaired children is needed. 
A formal quality of life assessment for the patient and caregivers is also 
needed.   
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Chapter 5 A comparison of three 
scoring systems to assess 
complications in a prospectively 
collected patient sample 
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5.1 Aim of the study 
To compare different scoring systems, for documenting outcomes, 
complications and morbidity after a surgical procedure. 
5.2 Methods 
A prospectively collected dataset of post-operative complications for two 
cohorts of patients were analysed according to the well-established Clavien-
Dindo classification (Dindo et al., 2004) (see Chapter 1.6.3), the newer 
Comprehensive Complication Index (Slankamenac et al., 2013) (see 
Chapter 1.6.4) and the PEG vs. RIG Complication score ( see Chapter 
2.4.7).  
5.2.1 Clavien-Dindo Classification 
The treatment used to correct the complication after a surgical procedure is 
the basis of this classification. It consists of seven grades (I, II, IIIa, IIIb, IVa, 
IVb and V) Table 1-3. It aims to eliminate reporting bias by including 
objective criteria, which are well documented and unambiguous.  
5.2.2 Comprehensive Complication Index (CCI) 
Rather than focussing on the most severe complication post-operatively, the 
CCI takes into account all the adverse events and gives a thorough account 
of the post-operative course. The developers have made readily accessible 
the CCI®-Calculator, which is an online tool for the assessment of 
postoperative complications and calculation of the CCI® in one single 
patient as well as in a group of patients. It is validated in adults but not in 
children.
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5.2.3 PEG vs. RIG Complication Score 
 
Although the above scoring systems have been validated in adults, no 
validation has taken place in children. A direct comparison of complications 
can be misleading as the complications seen vary widely in severity. For 
instance, some published reports of minor complications took only wound 
site problems into account (Barron et al., 2000), while other reports also 
included delayed feeds and tube-related issues (Friedman et al., 2004, 
Malden et al., 1992). In addition, some patients may experience more than 
a single complication. Thus, we devised a gastrostomy complication scoring 
system specific for children, where complications were ascribed scores 
weighted for severity. We believe that the total score per patient is a more 
accurate reflection of the success of the procedure. The score was devised 
in a consensus meeting attended by experts in the field (paediatric 
surgeons, interventional radiologists, junior doctors and nurses, Table 2-2). 
However, this score is not validated. 
5.3 Results 
The scores according to each of the three systems for each patient in the 
PEG vs. RIG trial were calculated. A few sample patients are described 
below (Clavien-Dindo classification followed by CCI using, the CCI®-
Calculator and then the PEG vs. RIG complication score). 
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Patient 7 
Clavien-Dindo Classification: II 
 
PEG vs. RIG score: 4 
Patient 54 
Clavien-Dindo Classification: II 
 
PEG vs. RIG score: 3 
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Patient 18 
Clavien-Dindo Classification: II 
 
PEG vs. RIG score: 26 
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Patient 75 
Clavien-Dindo Classification: 0 
 
PEG vs. RIG score: 0 
Patient 208 
Clavien-Dindo Classification: II 
 
PEG vs. RIG score: 6  
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Patient 82 
Clavien-Dindo Classification: I 
 
PEG vs. RIG score: 1 
 
5.4 Discussion 
The prospectively collected post operative complications for patients in the 
PEG vs. RIG trial was analysed using the three scoring systems. The 
relationship between scores was analysed using linear regression; the PEG 
vs. RIG complication scores and the CCI show a significant positive 
relationship (Figure 5-1).  
Scoring Comparison 
 110 
0 1 0 2 0 3 0
0
2 0
4 0
6 0
P E G -R IG  s c o re
C
C
I
 
Figure 5-1 Linear regression analysis of CCI against PEG vs. RIG score   
R2=0.59, P<0.0001 
If the four outliers with a PEG vs. RIG score of more than 20 are removed 
(Table 5-1), the linear relationship becomes stronger (Figure 5-2). There 
were 2 patients each with a PEG and RIG. Patient 71 had a gastro-colic 
fistula, which required a laparotomy 10 days later for closure of the fistula 
and re-siting of gastrostomy. Patient 131 developed an abscess, which 
needed aspiration under a general anaesthetic. Both these patients have a 
high PEG vs. RIG score and CCI score. Patient 17 had a buried bumper, 
which required a general anaesthetic. Patient 18 had severe gastro-
oesophageal reflux and had multiple problems with infection, discharge, 
leakage and granulation tissue, none requiring a general anaesthetic.  
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Figure 5-2 Linear regression analysis of CCI against PEG vs. RIG score without 
outliers   
R2=0.76, P<0.0001 
There were 7 patients (Table 5-2) with high CCI of more than 40 and low 
PEG vs. RIG score (between 7-9). These patients had multiple episodes of 
infection and wound site discharge. They required antibiotics which score a 
Patient ID PEG/RIG PEG vs. RIG CD CCI 
71 RIG 20 3 33.7 
131 RIG 22 3 40.6 
17 PEG 24 3 36.9 
18 PEG 26 2 48.6 
Table 5-1 Comparison of scores for patients with PEG vs. RIG score greater than 20 
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higher score on CCI and Clavien-Dindo grade, whereas on the PEG vs. RIG 
score, these are only classed as minor complications, with a score of 1. 
This highlights the potentially subjective nature of these scoring systems, 
and also possibly differences in clinician perception of severity of 
complication between adults (CCI and Clavien-Dindo) and children (PEG 
vs. RIG score). 
Patient ID PEG/RIG PEG vs. RIG CD CCI 
10 PEG 7 2 40.2 
21 PEG 7 2 40.2 
112 RIG 7 2 40.2 
176 RIG 7 2 40.2 
195 PEG 7 2 40.2 
104 PEG 8 2 40.2 
69 RIG 9 2 41.1 
 
Table 5-2 Comparison of scores for patients with CCI score greater than 40 
 
5.5 Conclusions 
In general, the well-validated CCI scoring system in adults closely mirrors 
the PEG vs. RIG scoring system. The PEG vs. RIG scoring may be a 
suitable indicator for this group of patients, as it is specific for the operation 
they underwent. However, a scoring system, which is specific for the 
paediatric population undergoing any surgery, is much needed, especially in 
an era when publication of surgical outcome data is mandated. 
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Chapter 6 Paediatric complexity 
index: preliminary study of a 
novel tool to measure morbidity 
in the paediatric surgical patient 
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6.1 Background 
In 1911, Ernest Codman after being ostracised from Massachusetts General 
Hospital in Boston opened the ‘End Result Hospital’. He focussed on the End 
Result system, which in his words was, “The common sense notion that 
every hospital should follow every patient it treats, long enough to determine 
whether or not the treatment has been successful, and then to inquire, ‘If not, 
why not?’ with a view to preventing similar failures in the future” (Brand, 
2009). He followed each patient up for at least a year and made public any 
complication they had, to improve future care. He believed that the patient 
should be able to make an informed decision about his/her treatment. He 
advocated that this system should be used to judge surgeons and determine 
promotions, rather than seniority. A hundred years ago he was well ahead of 
his times and was disliked by many of his colleagues.  
More recently, closer to home, Professor Sir Ian Kennedy who chaired the 
public enquiry into the high number of deaths after cardiac operations in 
babies at the Bristol Royal Infirmary (Smith, 1998), recommended that clinical 
teams should publish their results as individuals and as hospital units. The 
manner in which this information is collected and analysed remains 
controversial. There is widespread scepticism amongst the various surgical 
specialities about the susceptibility of misinterpretation by the media and 
public. However, despite this the Society for Cardiothoracic Surgery in Great 
Britain and Ireland (SCTS) has been publishing their outcome statistics for 
NHS hospitals and individual surgeons on their website since 2005 - 
accessed (2017). Their intention was to reinstate the public’s confidence as 
well as to provide a means for constructive feedback to individual surgeons 
and units.  
The Royal College of Surgeons encourages the publishing of individual 
outcome data onto the public domain such as NHS Choices. They have 
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provided consultant specific outcome data for 28 commonly performed 
operations for more than 5,000 consultant surgeons in the UK. Such data is 
important for individuals’ appraisal and revalidation as well. However, there is 
no such data for any paediatric surgical procedures. Recently there has been 
an initiative by the British Association of Paediatric Surgeons to enter 
consultant outcome data for two specific paediatric surgical conditions - 
hypospadias and gastroschisis. Currently this is voluntary, however 
participation in the database is a pre-requisite for revalidation. The data will 
be cross-checked against the Hospital Episodes Statistics data (UK) and ISD 
(Scotland). There is a need for risk stratification especially in complex 
operations with a very complex case mix of background conditions. Risk 
stratification is important for the following reasons (Keogh et al., 1998): 
1. So as not to judge individual surgeons performing high-risk 
procedures in complex patients unfairly against those performing the 
same procedures in otherwise ‘well’ patients. 
2. So that the high-risk patients are identified beforehand and a fully 
informed pre-operative consent can take place. The information will 
also help mitigate the reluctance of the surgeon to operate in these 
high-risk cases for fear of being penalised. 
3. So that the often overlooked influences of medical management and 
referral, anaesthetic care and intensive care resources can be 
accounted for. This can help build the case for improvement of 
facilities and support where necessary. 
The importance of accurate risk stratification is highlighted by the recent 
media controversy regarding results and potential closures of paediatric 
cardiac surgical centres. Although progress has been made in risk 
stratification for predicting post-operative outcomes in the adult population, 
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there remains an acute need for such a system in the paediatric population. 
The POSSUM (Physiological and Operative Severity Score for the 
enUmeration of Mortality and Morbidity) has been applied to a number of 
adult surgical groups including orthopaedic patients, vascular surgery, head 
and neck surgery and gastrointestinal/colorectal surgery (Copeland et al., 
1991). Similarly, the Clavien-Dindo and Comprehensive Complication Index 
have been validated and successfully used in the adult population (Chapter 
1).  
Paediatric physiology scoring systems such as PELOD Score (Pediatric 
Logistic Organ Dysfunction), Paediatric Risk of Mortality (PRISM) score and 
the Paediatric Index of Mortality (PIM) are focussed on the acutely unwell 
paediatric patient in intensive care and calculates the mortality risk (Slater et 
al., 2003, Pollack et al., 1988, Leteurtre et al., 2003). 
There is a need for an outcome predicting tool taking into account the post-
operative complication which is designed specifically for the paediatric 
surgical population. The paediatric patient is unique and cannot be compared 
to a standard adult. Their physiology and therefore acute response to stress 
is different. The special group of complex paediatric patients have multiple 
factors affecting their post-operative outcome and should be taken into 
account. There is no score that takes into account the background conditions 
unique to much of the paediatric surgical population.  
6.2 Aims of the study 
My aim was to develop a Paediatric Complexity Index (PCI) that integrates 
the pre-operative complexity of paediatric patients with all post-operative 
events. The purpose of this tool is twofold. Firstly, to provide context related 
outcome measures to empower patients and parents to make informed 
choices and secondly, to serve as an appraisal tool for surgeons, while not 
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compromising those surgeons dealing with ‘complex’ child and to ‘prove’ a 
units performance. 
6.3 Methods 
I developed the PCI along with two paediatric surgical colleagues. Nine 
routinely recorded physiological and eight operative measures were taken 
into account. Factors were weighted so that severe co-morbidities score 
more heavily than multiple co-morbidities of lesser severity (Table 6-1). The 
weighting was done after a brainstorming session between three paediatric 
surgeons. It was then circulated, amended and agreed upon by all the 
Consultant paediatric surgeons in the department. In this study I did not use 
any muti-level modelling. 
As a feasibility study I planned to run the PCI score on twenty patients. The 
project was registered with the hospital audit department (Registration 
number 1482). Ten patients with complex medical background and ten ‘non-
complicated’ patients who underwent operations between January 2014 and 
September 2014 were scored using the PCI. These were compared with 
Comprehensive Complication Index (CCI) by linear regression analysis. 
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6.4 Results 
Twenty patients were reviewed, ranging from age 0 days to fifteen years at 
time of operation (median 2.5 years). Ten patients had complex pre-operative 
status and underwent major operation while 10 patients were less complex 
and underwent intermediate operation (Table 6-2). 
PCI correlated closely with CCI (R2=0.54, p=0.0002, Figure 6-1). Several 
patients with physiologically abnormal parameters scored > 0 on PCI but 0 on 
CCI (i.e. no complications) highlighting that having a high PCI does not 
necessarily mean that they will have a complication but if they do have a 
complication then they are much more likely to have a high PCI. 
  
0 5 1 0 1 5 2 0 2 5
0
2 5
5 0
7 5
1 0 0
1 2 5
P C I
C
C
I
Figure 6-1 Linear regression analysis of CCI against PCI 
R2=0.54, p=0.0002 
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Age Operation PCI CCI 
0.0 
 
 
0.18 
 
 
15.2 
 
 
13.6 
 
5.3 
 
 
 
0.43 
 
 
0.51 
 
 
0.12 
 
6.15 
 
0.01 
 
6.11 
 
0.19 
 
3.44 
 
1.05 
 
0.36 
 
1.5 
 
10.4 
 
4.3 
 
3.4 
 
 
9.7 
 
Ex 23 week gestation, TOF/OA, repaired, hickman line, 
NEC laparotomy, multi-organ failure 
 
Ophthalmological operation, NEC post-op, laparotomy, 
wound dehiscence, stoma hernia 
 
Intestinal dysmotility, stoma formation, multiple trips to 
theatre, prolonged stay +++ 
 
Crohns, fistula ++, multiple laparotomies 
 
Trisomy 21, pulmonary hypertension, multiple admissions, 
gastro-oesophageal disconnection; roux loop needed 
lengthening 
 
Obstruction post-Duhamel pull through needed return to 
theatre 
 
Parastomal hernia in newly formed stoma, revised at 
laparotomy 
 
Ex premature, NEC, loss of most of bowel 
 
Ovarian tumour, return to theatre for bleeding 
 
Pulmonary stenosis, NEC post-op requiring laparotomy 
 
Closure of gastrostomy 
 
Laparoscopic inguinal hernia repair 
 
EUA anus + washout + revision anoplasty 
 
Right orchidopexy 
 
Laparoscopic inguinal hernia repair 
 
Right branchial sinus excision 
 
Roux en Y surgical jejunostomy 
 
Removal of gastrostomy 
 
Inguinal hernia repair, umbilical revision, insertion of 
grommet 
 
(Crohn’s) ileal stricture  resection 
     19 
 
 
14.5 
 
 
13 
 
 
19 
19 
 
 
 
8 
 
 
10.5 
 
 
24 
 
7 
 
16.5 
 
9 
 
1 
 
7 
 
5 
 
10 
 
2 
 
10 
 
8 
 
3 
 
 
8 
 
100 
 
39.7 
 
 
58.3 
 
 
99.9 
35.9 
 
 
 
47.7 
 
 
33.7 
 
 
58 
 
33.7 
 
20.9 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
8.7 
 
0 
 
0 
 
 
0 
 	
Table 6-2 Patient characteristics, operation, PCI and CCI scores 
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6.5 Discussion 
To maintain practical usability of the PCI it is important to include the factors 
most likely to have an effect on outcome, while not overcrowding and making 
the tool cumbersome. The PCI results from my pilot study are promising. 
However, it needs two-stage validation. The first is at the development stage. 
This can be done by enlisting a group of closely related physicians and 
surgeons (i.e. paediatric anaesthetists, paediatric intensivist and paediatric 
surgeons) to review the PCI parameters and their weighting. This cohort of 
assessors or the ‘development cohort’ can individually agree or disagree and 
remove or add further parameters. The result will then be compiled and the 
final PCI will be developed, by using appropriate mathematical formulae. 
The second stage will be validation of the developed PCI. This can be 
achieved by the following methods: 
1. Prospectively – Patients undergoing surgery will have their PCI 
calculated using the developed parameters. They will be reviewed until 
discharge or the first 30 days after the surgery, to determine 
complications. After 30 days the CCI will be calculated. The appropriate 
statistical analysis to test the ability of PCI to predict CCI will be 
undertaken. The advantage of this method is that selection bias is low, 
although it is time consuming and one needs to wait for the first 30 days 
to evaluate CCI. 
 
2. Retrospectively – a cohort of patients who underwent surgery over a 
specified timescale can be analysed for their PCI and CCI. The 
appropriate statistical analysis can be applied to look at the relation of 
the two scores. This can be quicker to perform, however as the data is 
being collected retrospectively, there might be missing data leading to 
flawed result.   
 
Complexity Index 
 
122 
3. Quality of Life validation – A cohort of patients undergoing any 
operation can have their quality of life assessed by using the well 
validated EuroQol questionnaire EQ-5D (Brooks, 1996) at the time of 
discharge. The EQ-5D-Y (Wille et al., 2010) is designed for children and 
young adults. For the younger child, these can be filled in by the 
parents/carers. There would be expected to be a statistically significant 
negative correlation between PCI and the post-operative health status. 
 
4. Estimation of the severity of single vs. multiple comorbidity by conjoint 
analysis – The weighting of the various factors can be tested by 
developing scenarios with single or multiple complications and asking 
parents to score on a visual analogue scale. The values of these 
scenarios’ PCI can be calculated. These can be analysed using the 
principles of conjoint analysis (Bachmann et al., 2008).There should be 
a high positive correlation between the result of the conjoint analysis 
and the PCI.  
6.5.1 Sample size 
The sample size calculation of the validation cohort can be based on a pilot 
study, after there has been agreement at the ‘development cohort’ of the 
factors to include/exclude and their weightings. In addition, the sample size is 
very dependent on the scope of the proposed study (e.g. whether to include 
only patients having a post-operative overnight stay or also to include day 
surgery). The sample size should be able to detect a difference calculated 
from the pilot study and should have a power of 80% at a significance level of 
0.05, and provision of a dropout rate of 15%. 
6.5.2 Parent involvement 
There has been an increased awareness and participation of parents in the 
decision making process for children’s treatment. There are parents support 
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group for rare, complex conditions providing invaluable support to the affected 
families. We as surgeons have to work with them to ensure the best outcome 
for children.  
In the adult health services Patient Reported Outcome Measures are 
increasingly being used for key elective operations. In children a similar 
initiative using parents are likely to become popular, but there are many 
complexities in their development. 
6.6 Conclusions 
Our preliminary data suggests that the PCI is an accurate tool to stratify 
patients with regards to pre- and intra-operative morbidity and therefore 
optimise patients at greater risk of complications, as well as make more sense 
of post-operative complications. It requires further development and extensive 
validation in a variety of patient groups but has the potential to allow accurate 
comparison of complications between different centres taking into account 
individual patient characteristics. We also need to develop a readily available, 
easily accessible and simple to use online tool so that this is widely 
reproducible. 
I have had discussions with researchers involved in developing Patient 
Reported Outcome Measures at Oxford for adults. With their experience I 
hope this work can be taken forward to develop a similar model in children. 
This requires funding and pooling of resources from clinicians (paediatric 
anaesthetists, paediatric intensivist and paediatric surgeons) to non-clinicians 
such as health economists, psychologists, statisticians and website 
development specialist. 
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Chapter 7 General Discussion
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Despite enteral feeding being the preferred mode of nutrition in the ‘unwell’ 
child, there is no consensus on the safest way to insert a gastrostomy, after a 
period of nasogastric tube feeding. There is considerable disagreement 
between gastroenterologists and paediatric surgeons and amongst paediatric 
surgeons themselves. There are advocates of the PEG, the RIG and the 
laparoscopic assisted gastrostomy. The two most common procedures 
performed at Great Ormond Street Hospital are PEG and RIG. In a 
retrospective study done at our institute, RIG was found to have more 
complications than PEG. This meant that ethically RIG should not be 
performed. However, there were drawbacks of the retrospective study in that 
the study population was not matched. In order to verify the results from the 
retrospective review, it was essential to perform a prospective randomised 
controlled trial.  
 
In the research described in this thesis I have attempted to answer this 
question using one of the highest levels of evidence. The results of the trial 
showed that there is no difference between total number of complications or 
the rate of complications, following PEG or RIG. This has important impact 
on centres practising both the methods of gastrostomy insertion. It can lead 
to streamlining of patient treatment to the more readily available option 
without any concerns about difference in outcomes. Further study of this 
cohort of patients can provide information about the development of gastro-
oesophageal reflux, need for further feeding device or resolution of 
symptoms and establishment of oral feeding. Further follow-up of these 
patients will indicate whether the equal efficacies of these procedures are still 
apparent at a later date. 
While conducting the randomised controlled trial I was faced with ethical 
dilemmas with children in special circumstances such as social care, 
palliative care and with rare diseases. These circumstances along with the 
anatomy and physiology of these children make them unique and 
incomparable with adults. 
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I looked at the complications associated with a gastrostomy. The major 
complication of buried bumpers can sometimes be life threatening and at 
other times picked up as an incidental finding when the disc device is being 
changed to a balloon gastrostomy device. The incidence of this complication 
is not really known and reflects the reluctance to report it. I reviewed the 
literature and reviewed our own experience with gastrostomies over a 12-
year period. This retrospective review was enhanced by undertaking a 
focussed telephonic interview to investigate care of the gastrostomy before 
and after the episode of buried bumper. The study showed that proper care 
and device maintenance are essential in preventing this complication. I also 
investigated the treatment options. 
Children unable to tolerate gastric feeding, frequently as a result of gastro-
oesophageal reflux, can have jejunal feeding. There is no long-term outcome 
study looking at the efficacy of jejunostomy feeding in children. The two 
commonly used methods at our institute are SJ and RGJ. The important 
aspect of any feeding method is the end result of ability to meet nutritional 
requirements and to maintain growth. I reviewed the complications and 
nutritional outcomes following jejunostomy placement (SJ or RGJ) at our 
institute. Both SJ and RGJ are able to maintain and improve growth in a 
carefully selected group of children, although SJ and RGJ cannot be 
compared as they are used for patients at different stages in a spectrum of 
malnutrition. Perhaps it will be more prudent to compare nutritional 
outcomes, complications and quality of life outcomes in a randomised 
controlled trial comparing RJ and anti reflux procedures. From a patient and 
carer perspective the ease of using the feeding device and its maintenance 
play an important part in their everyday life.   
The reporting of complications after an operative procedure is not universal. 
There is either under reporting or no reporting at all. However, now with the 
Royal College of Surgeons making individual reporting of outcomes 
mandatory, the situation is likely to improve. The Clavien Dindo Grade 
followed by the more relevant Comprehensive Complication Index, are steps 
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towards transparent reporting of complication outcomes. However none of 
the available scoring systems take into account the background complexities 
specifically in children. I reviewed the available scoring systems for post-
operative complications and developed a new paediatric complexity scoring 
system of risk stratification for post-operative complications. I have explored 
various validation strategies for the developed paediatric complexity scoring 
system. Impact of the complexity of paediatric patients on their post-operative 
complications needs thorough consideration to improve outcomes following 
their operation. 
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Chapter 8 Publications & 
Presentations arising from this 
Thesis
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1. A double blind randomised controlled trial of percutaneous 
endoscopic gastrostomy vs. radiologically inserted gastrostomy 
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1. Background  
 
The use of gastrostomy tubes is a lifeline for long-term enteral nutrition in 
the pediatric patient in need of nutritional supplementation. Before 1980, 
the only method of gastrostomy insertion available was the open surgical 
technique. This is a relatively invasive procedure as it requires a separate 
formal surgical incision, and has been blamed for various adverse effects 
including precipitating gastroeosphageal reflux (1,2). It was Gauderer who 
first described his method of percutaneous endoscopic gastrostomy (PEG) 
in 1980 (3), which transformed the process by eliminating the need for a 
surgical wound. Since then, various minimally invasive techniques of 
gastrostomy insertion have been developed, including radiologically 
inserted gastrostomy (RIG) inserted under fluoroscopic guidance (4,5). 
Both methods of endoscopic and radiologically guided gastrostomy 
insertion have become established practice since they were first described 
nearly 3 decades ago  
Gastrostomy insertion is a procedure commonly seen in children. Although 
there are a number of publications on both methods in the adult population 
(6,7,8), there is little information available in literature specifically 
comparing the 2 techniques in the pediatric population. 
We carried out a review of 318 children who had either PEG or RIG 
insertion in our hospital between 2004 and 2008 (9). The conversion rate in 
the PEG group (8%) was higher than the RIG group (1%). This 
corresponds to a superior technical success rate of 97-100% reported in 
literature for the RIG technique (8,10-12). The majority of conversions were 
due to anatomical difficulties such as scoliosis and high position of the 
stomach with narrow subcostal angle, which are more likely to be present 
in neurologically impaired children. 
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Both PEG and RIG have the benefits of easy insertion and avoidance of 
laparotomy incision. However, both techniques are also associated with 
complications, including gastrocolic fistula, haemorrhage and intra-
abdominal leak with sepsis (6,7,13,14).  
In our study, the rate of major complications was low in both PEG and IG 
at 1% and 3% respectively (P=NS), which compared favourably to other 
reports (15-19). Patwardhan et al reported a 3.5% incidence of gastrocolic 
fistula in PEG over a 5 year period, a complication which was only seen in 
1 PEG patient in our series (17). Other major complications have been 
described including placement of the catheter through a lobe of the liver, 
fistulation into the small bowel and ‘buried bumper syndrome’ 
(16,19,20,21). 
We also reported that the overall number of patients who developed both 
major and minor complications were lower in PEG compared to RIG (28% 
vs 47%, P=0.001). This may have been due to the difference in case mix 
where more IG patients were immunocompromised to some degree due to 
chemotherapy for their underlying oncological illness. As reported by 
Barron et al, nearly half the patients in a series of pediatric 
hematology/oncology patients had localized tube site infection after IG 
insertion (19). In a study of late-onset complications of PEG in children by 
Segal et al, the overall rate of complications was 44% observed over a 
follow-up period of 1 to 8 years (22). 
A direct comparison of complication rates can be inaccurate as the 
complications seen varied widely in severity. For instance, some published 
reports of minor complications took only wound site problems into account 
(19), while other reports also included delayed feeds and tube-related 
issues (11,12). In addition, some patients may experience more than a 
single complication. Thus, we devised a gastrostomy complication scoring 
system where complications were ascribed scores weighted for severity. 
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We believe that the total score per patient is a more accurate reflection of 
the success of the procedure.  
One aspect of any surgical procedure that is becoming increasingly 
relevant today is a comparison of costs. Barkmeier et al indicated in their 
report that PEG was the less costly procedure (8). However, this 
advantage was lost when the need for operating theatre facilities and 
general anesthesia were factored in. Costs may also be further reduced 
with the use of primary gastrostomy button placements, reducing the 
number of tube changes required (23). 
Given the lack of robust evidence that one method is superior to the other, 
we are proposing a randomised controlled trial to establish if PEG is better 
than RIG in outcome and complications. 
2. Aims  
 
The aim of this study is to demonstrate the most effective method of 
gastrostomy insertion in children. The hypothesis to be tested is that 
percutaneous endoscopic gastrostomy (PEG) is superior to 
radiologically inserted gastrostomy (RIG) in terms of outcome and 
complications. 
 
3. Research Objectives  
 
The proposed trial will define which technique is more effective: PEG or 
RIG.  
 
The scientific reasons to justify such a trial are the following:  
1. Gastrostomy insertion is a widely and frequently used procedure 
in children.  
2. The ideal method of gastrostomy insertion is not known. 
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3. Both PEG and RIG can be associated with a number of 
complications (e.g. gastrocolic fistula, intra-abdominal leak with 
sepsis).  
   
 
4. Methods  
 
This will be a double blind single centre randomized controlled trial. 200 
patients (100 in each arm) will be randomized to either PEG or RIG. 
Patients will be allocated to groups by weighted minimization (24). 
Minimization is a method of randomized treatment allocation, which 
ensures that the groups are balanced with respect to prognostic 
indicators (minimization criteria) that are likely to affect patient outcome. 
Minimization criteria used are detailed in Table 2. 
 
The inclusion criteria for the study will be:  
1. any child referred for gastrostomy insertion 
  
 The exclusion criteria for the trial are:  
5. the child has gastro-esophageal reflux and is being considered for 
anti-reflux surgery 
6. previous gastrostomy or fundoplication 
7. previous extensive abdominal surgery 
8. the child requires a concomitant major procedure on the gut or 
other intra-abdominal organs 
 
Every referral for a gastrostomy will be assessed by the trial coordinator 
(Research Fellow) for the inclusion and exclusion criteria. If the 
exclusion criteria are absent, the parents or care giver of the referred 
child will be asked consent for inclusion in the trial and consequently for 
randomization. The patient will be randomized online using a fast and 
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simple method (or using the toss of a coin as back-up) to either PEG or 
RIG. 
 
If the child is judged to be of suitable age and maturity, every attempt 
will be made to provide as much information as appropriate to the child 
regarding participation. 
 
If consent for participation in the trial is refused, the parent or guardian 
will be approached for consent for data collection to continue even 
without participation in the trial. This data will also be analysed. They 
will also be invited for follow-up according to the trial schedule. 
 
The primary end point of the study will be the total number of 
complications (major and minor). 
 
The secondary end points of the study will be:  
viii. major complication rate : colonic injury or gastrocolic fistula or other 
visceral injury, peritonitis requiring surgery, intestinal obstruction 
requiring surgery, major gastrointestinal bleed, other complications 
requiring surgery 
ix. minor complication rate : infection requiring systemic antibiotics, 
delay more than 48 hours in establishing feeds, granulation, wound 
site discharge, tube-related problems (migration, dislodgement, 
leakage, breakage), other minor 
x. complication score : this is a score devised with weighting assigned 
to each complication depending on the severity of the complication, 
as detailed in Table 1. The score was devised in a consensus 
meeting attended by experts in the field (paediatric surgeons, 
interventional radiologists, junior doctors and nurses. 
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 Type of complications Score 
Major 
complications 
Colonic injury / gastrocolic fistula 20 
Peritonitis requiring surgery 20 
Intestinal obstruction requiring surgery 20 
Major gastrointestinal 
bleed 
Requiring surgery 20 
Requiring transfusion but 
not surgery 
10 
Buried Bumper 20 
Other complications requiring surgery 20 
Minor 
complications 
Infection requiring systemic antibiotics 1 
Delay more than 48 hours in establishing feeds 1 
Granulation 1 
Wound site discharge 1 
Tube-related problems Migration 1 
Pulled out / dislodged 5 
Leakage around tube 2 
Breakage 2 
Other minor 2 
 
Table 1: Gastrostomy scoring system for complications of gastrostomy insertion 
 
xi. technical failure : these are the number of PEG or RIG that are 
unsuccessful and require conversion to open surgical gastrostomy 
or laparoscopic gastrostomy. 
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xii. difficulty of procedure : this will be assessed by the operator as : 1) 
easy, 2) slightly difficult (but does not warrant conversion 3) difficult 
(warrants conversion) 
xiii. cost of hospital treatment 
xiv. mortality 
xv. cause of death 
9. Randomisation  
 
Patients will be allocated to groups by weighted minimization (23). 
Minimization is a method of randomized treatment allocation, which 
ensures that the groups are balanced with respect to prognostic 
indicators (minimization criteria) that are likely to affect patient outcome. 
Minimization criteria used will be the criteria laid out in Table 2. 
 
Table 2 : Minimisation Criteria 
6. Statistics and Sample Size Estimation  
 
For sample size estimation, we used a binary power calculation, i.e. 
proportion of patients with any complications in each group.  
Minimisation Criteria Definition 
Diagnosis [Neurological] [Haematology/Oncology] [Metabolic] 
[Gastrointestinal Diseases] [Miscellaneous] 
Age 
[< 6months] [6 months – 2 years] [2 – 5 years] [>5 
years] 
Weight Centile [<3%] [3-10%] [10-25%] [25-50%] [>50%] 
Inpatient Status [Yes] [No] 
Scoliosis  [Yes] [No] 
Gastro-esophageal 
reflux 
[No] [Yes- Not needing anti-reflux surgery] 
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From our previous retrospective review of 318 children who had either 
PEG or RIG (9), 28% of PEG patients and 47% of RIG patients had 
complications.  
To detect a difference of 19% (80% power, α=0.05), 100 patients per 
group are needed. 
In our hospital, we perform a large number of gastrostomies per year 
(between 3-5 per week), and are confident that 200 patients in total will 
be recruited within 2 years. 
Outcomes will be compared using appropriate regression analyses 
(linear, binary or Poisson), accounting for all the minimisation criteria. 
Data will be analysed on an intention to treat basis. We anticipate that 
with the trial powered for a binary outcome, we will have adequate 
power to examine outcomes using regression analyses.  
The primary outcome will be analysed using zero-inflated Poisson 
regression analysis of complication score per patient over time. A zero-
inflated  Poisson distribution is expected on the basis of our 
retrospective review of complication scores in patients undergoing 
gastrostomy insertion. 
 
7. Treatment Schedules  
 
Procedures will be performed by consultant radiologists, 
gastroenterologists or paediatric surgeons; or by trainees at specialist 
registrar level under direct supervision by a consultant on site. All cases 
will be done under general anaesthesia with prophylactic antibiotics 
administered before the procedure. A 9 French silicone gastrostomy 
tube will be used. 
The two standardized procedures compared in the trial are: 
 
Percutaneous Endoscopic Gastrostomy 
After insufflation of the stomach with an endoscope, indentation of the 
stomach and transillumination through the abdominal wall is confirmed 
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under endoscopic vision. A small incision is made over the area of 
maximum transillumination and a catheter mounted on a needle passed 
through followed by a guidewire (Seldinger technique). The guidewire is 
grasped by the endoscope, pulled out through the mouth and attached 
to the gastrostomy tube which is then pulled antegrade and out through 
the abdomen. The tube was is with an external fastener and no sutures 
were placed. 
 
Radiologically Inserted Gastrostomy 
This is done using biplane fluoroscopy, with pre-placement 
ultrasonography for localization of the liver. An orogastric snare is passed 
and the stomach punctured under fluoroscopic guidance with an 18-gauge 
needle which is used to insert a stiff 0.035-in guidewire.  This is snared and 
withdrawn through the mouth.  The snare catheter is introduced in a 
retrograde direction from the abdominal wall to the mouth, and the 
gastrostomy tube is grasped and pulled down the esophagus. 
 
The stages of the study will be as follows: 
 
Stage 1 – Enrolment 
i)  Patient is identified as eligible 
ii)  Consent is obtained from parent or guardian 
iii) Demographics recorded and treatment randomized via 
internet 
Stage 2 – Day of Procedure 
Details of operative procedure (technical failure, difficulty of 
procedure, operator details) 
Stage 3 – Postoperative period 
Data is collected until discharge of the patient from hospital. 
Stage 4 – Postoperative Follow-up 
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                           Patients are re-evaluated at 6 weeks ± 2 weeks, 6 months± 1 
month, 1 year ± 2 months and 3 years ± 2 months after the 
procedure. Complications are recorded and scored. 
If by the time of evaluation, the participant has had the gastrostomy 
removed, and there is no clinical indication for follow-up, the 
evaluation will be done by remote interview (telephone or email). 
 
8. Double Blind 
 
The patient and parents or guardian will be blinded to the method of 
gastrostomy insertion used. The research nurse or research fellow 
assessing the complications will also be blinded. 
 
9. Data Monitoring and Interim Analysis  
 
Participants will be allocated a unique study number, and all study data 
will be stored with this number as the identifier. Identifiers will be held in 
a separate database. This separation will happen at the time of 
transcribing the data.  
 
To ensure that the trial progress is in accordance with guidelines for 
good clinical practice in multicentre trials, the following Committees will 
be established:  
 
1. Data Monitoring and Ethics Committee which will be independent of 
both the trial organisers and those providing therapy. This 
committee will perform interim analyses to: a) review assumptions 
underlying sample size considerations; b) modify or close intake to 
trial.  
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2. Trial Steering Committee which will include: i)independent Chairman 
(not involved in Trial); ii) two independent members (Paediatric 
Surgeon and Paediatrician); iii) nurse representative; iv) parents’ 
representative; v) trial coordinators (AP, PDC and SE); vi) research 
fellow; vii) representative of the Data Monitoring and Ethics 
Committee. A statistician will attend meetings as appropriate. The 
role of this Committee is to provide overall supervision of the trial 
and ensure that the trial is conducted to rigorous scientific, clinical 
and ethical standards. It will particularly concentrate on progress of 
the trial, adherence to trial protocol, data collection and maximize 
the chances completion within the agreed time-table. 
 
Data will be analysed at the Institute of Child Health and will be 
compared by appropriate parametric or non-parametric analyses. We 
will convene a Data Monitoring and Ethics Committee who will review 
the data when 100 patients have been recruited.  
The criteria for stopping the trial will be defined as: (i) a significant 
difference (p<0.01) between the two arms overall complication rate; or 
(ii) significantly (p<0.01) greater incidence of major complications; in 
one arm compared to the other, analysed both as single outcomes and 
as total cumulative complications. 
10. Compliance  
 
In order to maximise compliance in the trial there will be a part time 
Research Fellow who will liaise with the clinical teams involved. 
Confidentiality of data will be ensured.  
 
11. Timetable  
 
0-1 months: establish trial, complete Research Ethics Committee 
approvals, develop data management systems and databases; 2-24 
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months: recruitment, randomisation and follow-up; 25-60 months: 
Complete analyses, write final report for peer review publication.  
 
12. Relevance  
This trial addresses a fundamental question concerning the best 
management for children requiring gastrostomy insertion. This trial will 
establish which is the best procedure (i.e. PEG or RIG) in terms of 
outcome and associated complications. 
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Date: 15/03/2013 
 
 
Parent Information Sheet 
[Gastrostomy] 
 
 
 
 
 
 
1. Study Title  
 
PEG vs. RIG Trial 
Percutaneous Endoscopic Gastrostomy versus 
Radiologically Inserted Gastrostomy in children 
 
 
2. Invitation Paragraph  
You and your child have been invited to take part in a research study. 
Before you decide whether to take part it is important for you to understand 
why the research is being done and what it will involve. Please take time to 
read the following information carefully and discuss it with others if you 
wish. Ask us if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part.  
Thank you for reading this.  
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3. What is the purpose of the study?  
You have been advised that your child requires a gastrostomy. A 
gastrostomy is a feeding device that is inserted through an opening in the 
abdomen to the stomach. This allows your child to be fed directly into his 
or her stomach, bypassing the mouth and throat.  
People who have difficulties feeding can benefit from a gastrostomy. There 
are many reasons why someone might have difficulties feeding, including 
neurological (nervous system) disorders and gastrointestinal (digestive 
system) disorders. Some people also have difficulty swallowing, which 
increases the chance that they will breathe in food (aspirate).  
Others who may benefit are those who are able to feed and swallow 
normally, but are unable to maintain an adequate intake for healthy weight 
gain. This usually occurs in times of severe illness, such as a child with 
cancer or leukaemia who is undergoing chemotherapy. 
There are 2 common methods of inserting a gastrostomy under general 
anaesthesia: 
1) Percutaneous endoscopic gastrostomy (PEG) 
This is inserted under the guidance of an endoscope (a flexible 
instrument with a camera at the end that is used to inspect the 
stomach). It is done by a gastroenterologist or paediatric 
surgeon. 
2) Radiologically inserted gastrostomy (RIG) 
This is inserted under the guidance of radiological imaging, 
including ultrasound and video X-rays. It is done by a radiologist. 
Both methods are widely used in many centres around the world, and are 
the 2 most common methods used in our hospital. 
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Despite the fact that both methods have been used for many years, we do 
not know which is better in terms of outcome and complications. This study 
will determine which method is the best. 
4. Why have I been chosen?  
Your child has been chosen because he/she requires a gastrostomy. The 
hospital and consultants taking part in the study are experienced in both 
operations and regularly perform both in children.  
We are planning to recruit 200 children in this study.  
5. Do I have to take part?  
It is up to you to decide wether or not to take part. If you decide to take part 
you will be given this information sheet to keep and be asked to sign a 
consent form. If you decide to take part you are still free to withdraw at any 
time and without giving a reason. A decision to withdraw at any time, or a 
decision not to take part, will not affect the standard of care your child 
receives. Your child will still receive a gastrostomy which he/she 
requires anyway, but will not be part of the research. 
6. What will happen to my child if I take part?  
Because we do not know which procedure is best for patients, we need to 
make comparisons. Children participating in this study will be put into one 
of two groups and then compared (randomised trial). The groups are 
selected using computer software which has no personal information about 
the individual – i.e. by chance. One group of children will then have the 
PEG and the other will have the RIG.  
7. What do I have to do?  
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There will be no changes in the care to your child while he/she is 
participating in the study.  
8. What is the procedure that is being tested?  
Both procedures are being compared in this study.  
9. What are the alternatives for treatment?  
There are other methods of gastrostomy insertion but these are usually 
used when a PEG or RIG has been already inserted or when the surgeon 
anticipates some difficulty.  
We believe that since your child has never had a gastrostomy inserted in 
the past, either PEG or RIG would be the most appropriate method. 
10. What are the side effects of any treatment received when taking 
part?  
Within the trial, your child will not receive any treatment other than the 
gastrostomy insertion. Your child will be closely monitored before and 
during the operation and on the ward after the operation.  
All other care that your child would normally have will continue as usual. 
There are no blood samples or any other samples that will be taken as part 
of the research. 
11. What are the possible disadvantages and risks of taking part?  
There are risks associated with all types of surgical procedures and your 
doctor will discuss these with you. There are no known disadvantages or 
risks for your child in taking part in this study over and above those risks 
that are associated with the procedures.  
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12. What are the possible benefits of taking part?  
There is no intended clinical benefit to your child from taking part in the 
study. The information we get from this study may help us to improve the 
treatment of future children requiring a gastrostomy.  
13. What if new information becomes available?  
Sometimes during the course of a research project, new information 
becomes available about the treatment that is being studied. A ‘Data 
Monitoring Group’, whose role it is to consider any such information will 
meet to determine what action, if any, is required. If this happens, your 
research doctor will tell you about it and discuss with you whether you want 
to continue to have your child involved in the study. If you decide to 
withdraw, your research doctor will make arrangements for your child’s 
care to continue. If you decide to continue in the study you will be asked to 
sign an updated consent form.  
Also, on receiving new information your research doctor might consider it 
in your child’s best interest to withdraw them from the study. He/she will 
explain the reasons and arrange for your child’s care to continue.  
14. What happens when the research study stops?  
We will monitor your child’s progress for all the recovery times until 
discharge. Your GP will continue to monitor your child’s progress as part of 
normal clinical care.  
15. What if something goes wrong?  
There are risks associated with all types of surgical procedure and your 
doctor will discuss these with you. Both operations have similar risks 
associated with them. The study has no known risks to your child over and 
above those risks that are associated with the surgery. However, research 
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can carry unforeseen risks and we want you to be informed of your rights 
in the unlikely event that any harm should occur as a result in taking part in 
this study.  
The Institute of Child Health will provide no-fault compensation cover for its 
own staff involved in the trial. Regardless of this, if you wish to complain, or 
have any concerns about any aspect of the way you have been 
approached or treated during the course of this study, the normal National 
Health Service complaints mechanisms should be available to you.  
16. Will my taking part in this study be kept confidential?  
All information which is collected about your child during the course of the 
research will be kept strictly confidential. Any information about your child 
which leaves the hospital will have his/her name and address removed so 
that he/she cannot be recognised from it. With your permission your GP or 
paediatrician will be notified of your child’s participation in the study.  
17. What will happen to the results of the research study?  
The results of the study are likely to be published in medical journals. You 
can obtain a copy of the published results. Your child’s name will not be 
identified in any report or publication.  
18. Who is organising and funding the research?  
Doctors at the Institute of Child Health and Great Ormond Street Hospital 
for Children NHS Trust, London are organising this study. The study is 
being funded by Great Ormond Street Hospital Children’s Charity. Patients 
will not be paid to participate in the study.  
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19. Contact for Further Information  
Mr Joe Curry MBBS, FRCS(Eng), FRCS(Paed Surg)  
Consultant Paediatric Surgeon 
Great Ormond Street Hospital 
Great Ormond Street 
London WC1N 3JH 
Phone:+44 (0)20 7405 5871  
Fax:+44 (0)20 7813 8243 
Email: Joe.Curry@gosh.nhs.uk 
 
Miss Rashmi R Singh 
Clinical Research Associate, 
Paediatric Surgery Unit  
Institute of Child Health  
30 Guilford Street  
London WC1N 1EH UK  
Tel: +44 (0)20 7905 2682 
 
 
Thank you for considering taking part in this study. 
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Appendix 3 Data Collection Sheet 
Outpatient / Telephonic follow-up (Please circle): 
Patient Hospital Number ____________________  
 
Patient Name ______________________________  
 
Post gastrostomy: (Please circle) 6 weeks, 6 months, 1 year, 3 years 
Removal at_____ 
Complication scores (Please circle):  
If removed, why?________________________________________________ 
Any other concern_______________________________________________
Complications requiring surgery 20 
Infection requiring systemic antibiotics 1 
Delay more than 48 hours in establishing feeds 1 
Granulation 1 
Wound site discharge 1 
Tube-related problems Migration 1 
Pulled out / dislodged 5 
Leakage around tube 2 
Breakage 2 
Other minor__________________ 2 
PEG 
vs. 
RIG 
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Appendix 4 DMEC Report 
 
PEG vs. RIG Trial 
Percutaneous Endoscopic Gastrostomy versus Radiologically Inserted 
Gastrostomy in Children 
 
 
 
PEG vs. RIG Trial interim analysis 
Data Monitoring and Ethics Committee  
25th September 2013  
 
 
 
Miss Rashmi R Singh 
Clinical Research Fellow, UCL Institute of Child Health 
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3. PEG vs. RIG Trial  
 
 
3.1 Trial Details  
 
Title - Percutaneous Endoscopic Gastrostomy versus Radiologically 
Inserted Gastrostomy in Children: Randomized Controlled Trial 
3.2 Investigators  
Principal Investigator 
Mr Joe Curry MBBS, FRCS (Eng), FRCS (Paed Surg) 
Consultant Paediatric Surgeon 
Great Ormond Street Hospital 
Great Ormond Street  
London, WC1N 3JH 
Phone: +44 (0)20 7405 5871 
Fax:  +44 (0)20 7813 8243 
Email: joe.curry@gosh.nhs.uk 
 
Trial Coordinator 
Miss Rashmi R Singh 
Clinical Research Fellow 
Department of Paediatric Surgery   
UCL Institute of Child Health 
30 Guilford Street  
London, WC1N 1EH 
Email: rashmi.singh@ucl.ac.uk 
 
 
Registration Details 
Registration Reference Date 
R&D 10SG14 March 2010 
National Research and Ethics 10/H0713/47 October 2010 
Clinical Trials.gov Identifier NCT01920438 August 2013 
 
Trial Summary 
Trial Start  November 2011 
First Recruitment November 2011 
Trial End September 2014 
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3.3 Introduction 
Gastrostomy is the lifeline for many children with difficult or inadequate oral nutrition. 
It is usually performed in infants and children requiring short- to long- term enteral 
feeding. Neurologically impaired children with unco-ordinated and therefore unsafe 
swallow(Sleigh et al., 2004, Vernon-Roberts et al., 2010, Townsend et al., 2008); 
children undergoing or due to undergo intense chemotherapy resulting in intractable 
nausea and vomiting(Aquino et al., 1995, Schmitt et al., 2012, Pedersen et al., 1999, 
Mathew et al., 1996); children with metabolic disorders or renal failure requiring 
unpalatable medications or feeds in large volumes; children requiring a definite and 
secure means of enteral feed as a part of another surgical intervention (Urban and 
Terris, 1997, Al-Attar et al., 2012) and children with severe behavioral and 
gastrointestinal disorders have been greatly benefitted from this feeding 
device(Sathesh-Kumar et al., 2009, Nah et al., 2010). 
Percutaneous endoscopic gastrostomy (PEG), and radiologically inserted percutaneous 
gastrostomy (RIG) have the benefits of easy insertion and avoidance of a laparotomy 
incision. However, both techniques are also associated with complications, including 
gastro-colic fistula, haemorrhage and intra-abdominal leak with sepsis (Cosentini et al., 
1998, Vervloessem et al., 2009, Campos and Marchesini, 1999, Wollman et al., 1995). 
Although there are a number of publications on both methods in the adult population 
(Wollman et al., 1995, Cosentini et al., 1998, Barkmeier et al., 1998, Leeds et al., 2010, 
Blondet et al., 2010), there is little information available in literature specifically 
comparing the two techniques in the paediatric population.  
3.4 Study Hypothesis  
The aim of this study is to demonstrate the most effective method of gastrostomy 
insertion in children. The hypothesis to be tested is that percutaneous endoscopic 
gastrostomy (PEG) is superior to radiologically inserted gastrostomy (RIG) in terms 
of outcome and complications. 
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4 Data Monitoring and Ethics Committee (DMEC)    
4.1 DMEC Composition  
The Data Monitoring and Ethics Committee (DMEC) will be independent of 
both the trial organisers and those providing therapy. The members are listed 
below: 
• Professor Lewis Spitz, Chairman 
• Mr Niyi Ade-Ajayi, Member 
4.2 DMEC Remit  
 The committee will perform interim analyses to: 
1. Review assumptions underlying sample size considerations 
2. Modify or close intake to trial 
If there is overwhelming evidence of superiority of one treatment over the other 
the trial protocol recommends that the trial is stopped at this time. The trial 
stopping rules are described in full in table 1. 
Table 1 Trial Stopping Rules 
 
 
i. a significant difference (p<0.01) between the two arms 
overall complication rate; or  
ii.  significantly (p<0.01) greater incidence of major 
complications; in one arm compared to the other, analysed 
both as single outcomes and as total cumulative 
complications . 
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5 Trial Process  
This is a double blinded single centre randomised controlled trial. Two hundred 
patients (n = 100 in each arm) will be randomised to either PEG or RIG. Patients 
will be allocated to groups by weighted minimisation(Treasure and MacRae, 1998).  
The patient and parents or guardian will be blinded to the method of gastrostomy 
insertion used. The research nurse or research fellow assessing the complications 
will also be blinded. 
Procedures will be performed by consultant radiologists, gastroenterologists or 
paediatric surgeons; or by trainees at specialist registrar level under direct 
supervision by a consultant on site. All cases will be done under general anaesthesia 
with prophylactic antibiotics administered before the procedure. A 9 French 
silicone gastrostomy tube will be used. 
 
The two standardized procedures compared in the trial are: 
Percutaneous Endoscopic Gastrostomy 
After insufflation of the stomach with an endoscope, indentation of the stomach and 
transillumination through the abdominal wall is confirmed under endoscopic vision. 
A small incision is made over the area of maximum transillumination and a catheter 
mounted on a needle passed through followed by a guidewire (Seldinger technique). 
The guidewire is grasped by the endoscope, pulled out through the mouth and 
attached to the gastrostomy tube which is then pulled antegrade and out through the 
abdomen. The tube is fixed with an external fastener and no sutures placed. 
 
Radiologically Inserted Gastrostomy 
This is done using biplane fluoroscopy(Malden et al., 1992), with pre-placement 
ultrasonography for localization of the liver. An orogastric snare is passed and the 
stomach punctured under fluoroscopic guidance with an 18-gauge needle, which is used 
to insert a stiff 0.035-inch guidewire.  This is snared and withdrawn through the mouth.  
The snare catheter is introduced in a retrograde direction from the abdominal wall to 
the mouth, and the gastrostomy tube is grasped and pulled down the esophagus. 
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5.1     Sample size 
For sample size estimation, we used a binary power calculation, i.e. proportion of 
patients with any complications in each group.  
From our previous retrospective review of 318 children who had either PEG or 
RIG(Nah et al., 2010) , 28% of PEG patients and 47% of RIG patients had 
complications.  
To detect a difference of 19% (80% power, α=0.05), 100 patients per group are 
needed. 
Outcomes will be compared using appropriate regression analyses (linear, binary or 
Poisson), accounting for all the minimisation criteria. Data will be analysed on an 
intention to treat basis. We anticipate that with the trial powered for a binary 
outcome, we will have adequate power to examine outcomes using regression 
analyses.  
The primary outcome will be analysed using zero-inflated Poisson regression 
analysis of complication score per patient over time. A zero-inflated Poisson 
distribution is expected on the basis of our retrospective review of complication 
scores in patients undergoing gastrostomy insertion. 
 
5.2 Inclusion Criteria 
1. any child referred for gastrostomy insertion 
 
5.3 Exclusion Criteria 
1. the child has gastro-esophageal reflux and is being considered for anti-reflux 
surgery 
2. previous gastrostomy or fundoplication 
3. previous extensive abdominal surgery 
4. the child requires a concomitant major procedure on the gut or other intra-
abdominal organs 
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5.4 Randomisation and Minimisation Criteria  
Each referral for a gastrostomy will be assessed for the inclusion and exclusion 
criteria. If the exclusion criteria are absent, the parents or care giver of the referred 
child will be asked consent for inclusion in the trial and consequently for 
randomisation. The patient will be randomised online using a fast and simple 
method (SiMin® software, developed by the Institute of Child Health, UCL) to 
either PEG or RIG. 
 
Minimisation is a method of randomised treatment allocation, which ensures that 
the groups are balanced with respect to prognostic indicators (minimisation criteria) 
that are likely to affect patient outcome. This is based on the idea that the next 
patient to enter the trial is given whichever treatment would minimise the overall 
imbalance between the groups at that stage of the trial. Minimisation criteria used 
are detailed in Table 2. 
Minimisation Criteria Definition 
Diagnosis [Neurological] [Haematology/Oncology] [Metabolic] [Gastrointestinal Diseases] 
[Miscellaneous] 
Age 
 
[< 6months] [6 months – 2 years] [2 – 5 years] [>5 years] 
Weight Centile [<3%] [3-10%] [10-25%] [25-50%] [>50%] 
Inpatient Status [Yes] [No] 
Scoliosis [Yes] [No] 
Gastro-esophageal reflux [No] [Yes- Not needing anti-reflux surgery] 
  
Table 2: Minimisation Criteria 
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5.5 Outcome Measures  
The primary end point of the study will be the total number of complications (major 
and minor). 
 
The secondary end points of the study will be:  
i. major complication rate : colonic injury or gastro-colic fistula or other visceral 
injury, peritonitis requiring surgery, intestinal obstruction requiring surgery, 
major gastrointestinal bleed, other complications requiring surgery 
ii. minor complication rate : infection requiring systemic antibiotics, delay more than 
48 hours in establishing feeds, granulation, wound site discharge, tube-related 
problems (migration, dislodgement, leakage, breakage), other minor 
iii. complication score : this is a score devised with weighting assigned to each 
complication depending on the severity of the complication, as detailed in Table 
3. The score was devised in a consensus meeting attended by experts in the field 
(paediatric surgeons, interventional radiologists, junior doctors and nurses). 
 
 
 Type of complications 
 
Score 
Major 
complications 
Colonic injury / gastro-colic fistula 
 
20 
Peritonitis requiring surgery 
 
20 
Intestinal obstruction requiring surgery 
 
20 
Major gastrointestinal 
bleed 
Requiring surgery 
 
20 
Requiring transfusion but not 
surgery 
10 
Buried Bumper 
 
20 
Other complications requiring surgery 
 
20 
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Minor 
complications 
Infection requiring systemic antibiotics 
 
1 
Delay more than 48 hours in establishing feeds 
 
1 
Granulation 
 
1 
Wound site discharge 
 
1 
Tube-related problems Migration 
 
1 
Pulled out / dislodged 
 
5 
Leakage around tube 
 
2 
Breakage 
 
2 
Other minor 
 
2 
 
Table 3:Scoring system for complications of gastrostomy insertion 
 
iv. technical failure : these are the number of PEG or RIG that are unsuccessful and 
require conversion to open surgical gastrostomy or laparoscopic gastrostomy. 
v. difficulty of procedure : this will be assessed by the operator as : a) easy, b) 
slightly difficult (but does not warrant conversion) c) difficult (warrants 
conversion) 
vi. cost of hospital treatment 
vii. mortality 
viii. cause of death 
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6 Results 
 
6.1 Early Challenges 
Ethical amendments were obtained to alter the original protocol in order to correct and 
clarify various details of the study, and also to include a follow-up window. These were 
approved by the ethics committee and by the R&D team. The recruitment began in 
November 2011.  
The trial involves recruitment of patients needing a gastrostomy. These patients are 
under the care of various clinical teams including: General Surgery, Oncology, 
Haematology, Endocrine, Metabolic, Gastroenterology, and Nephrology. We organised 
departmental meetings and discussion with the clinicians involved in the care of the 
patients.  
For the assessment at follow-up of the patients, we organised training of nurses in the 
Somers Clinical Research Facility.  
Since then recruitment has progressed well. It has also sometimes been difficult to 
schedule patients for their procedure once recruited and allocated but now this process 
has been streamlined and runs effectively, so there is no delay in patients receiving a 
gastrostomy. 
6.2  Patients Recruited 
125 patients have been successfully recruited, over a period of 22 months. At this 
rate, I would expect to recruit the target of 200 patients by next year. The initial 
recruitment was slow due to the factors mentioned in the previous section. For the 
purpose of the DMEC the first 100 patients are being reviewed . 
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Figure 1: Chronological progress of patient recruitment.  
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6.3 Patient characteristics 
This section describes the characteristics of the patients recruited so far. At interim 
review, the results of 100 patients were available for analysis. 
 Categories Group A Group B ‘p’ value 
1.  Diagnostic Group: 
Neurological 
Haem-oncological 
Metabolic 
Gastrointestinal 
Other 
 
15 
12 
 6 
 2 
16 
 
13 
13 
 7 
 1 
15 
 
 
 
 
 
0.5415* 
2.  Age: 
< 6 months 
6 months- 2 years 
2-5 years 
> 5 years 
 
 3 
21 
14 
13 
 
 2 
21 
 9 
17 
 
 
 
 
0.8043* 
3.  Weight centile: 
<3% 
3-10% 
10-25% 
25-50% 
>50% 
 
16 
 9 
 7 
11 
 8 
 
16 
10 
 4 
10 
 9 
 
 
 
 
 
0.6213* 
4.  Inpatient/Outpatient: 
Inpatient 
Outpatient 
 
 5 
46 
 
 7 
42 
 
 
0.5501** 
5.  Scoliosis: 
Present 
Absent 
 
 0 
51 
 
 0 
49 
 
 
1** 
6.  Gastro-oesophageal reflux: 
Yes (controlled by medications) 
No 
 
14 
37 
 
8 
41 
 
 
0.2296** 
 Group totals: 51 49  
* Paired t-test 
** Fisher’s exact test 
Table 4: Patient Demographics and Clinical Characteristics 
There is no significant difference in the baseline demographic and clinical 
characteristics between the two groups. 
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6.4 Acceptance Rate 
In keeping with consort guidelines, we report our acceptance and recruitment to the 
trial, for the period of November 2011 to June 2013.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: CONSORT flow diagram of recruitment for the period of November 2011 to 
June 2013 
Assessed for eligibility (n= 176) 
Analysed  (n= 50) 
♦ Excluded from analysis (give reasons) (n=0) 
Lost to follow-up (n= 0) 
Discontinued intervention (End of treatment/ 
changed to a button device) (n= 8) 
Death (n= 4) 
Allocated to intervention (n=54) 
♦ Received allocated intervention (n=50) 
♦ Did not receive allocated intervention (n=4) 
• No longer needs intervention (n= 1) 
• Technical difficulty, different 
intervention (n=1) 
• Declined after allocation (n=1) 
• Needs further investigation (n=1) 
Lost to follow-up (n= 0) 
Discontinued intervention (End of 
treatment/ changed to a button device) (n= 
6) 
Death (n=3) 
Allocated to intervention (n=50) 
♦ Received allocated intervention (n=48) 
♦ Did not receive allocated intervention (n=2) 
• No longer needs intervention (n=1) 
• Technical difficulty, different 
intervention (n=1) 
Analysed (n=48) 
♦ Excluded from analysis (give reasons) (n=0) 
 
Randomized (n=104) 
Excluded  (n= 72) 
♦   Not meeting inclusion criteria (n= 14) 
♦   Declined to participate (n= 12) 
♦   Other reasons (n= 46) 
Enrollment 
Allocation 
Follow-Up 
Analysis 
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Seventy-two patients were not enrolled (using the CONSORT guideline (Moher et al., 
2010) for reporting Figure 2, summarizes the progress). Fourteen patients were not 
eligible, 12 patients declined to participate in the study. Forty-six patients were 
excluded due to various reasons – intervention not needed, terminally ill patient 
requiring the intervention as a part of palliative treatment, patients from abroad 
(therefore, difficult to be followed up), patient requiring concomitant procedure, 
patients with neuro-muscular disorder following a specific pathway for treatment.  
The 104 children enrolled were randomised to either PEG or RIG with weighted 
minimisation using the SiMin® software (Table 4). The median age at enrolment was 
2.4 years (range 4 months to 16 years).  
 
6.5 Outcomes 
 
Patients are evaluated at  6 weeks ± 2 weeks,  
6 months± 1 month,  
1 year ± 2 months and  
3 years ± 2 months after the procedure.  
 
 
 
 
Table 5: Number of patients completing follow ups 
 
 Seven patients died before completing three years of follow-up due to their advanced 
primary oncological disease (4 in Group A and 3 in Group B). One patient has had a 
major complication needing a laparotomy after the intervention. The others have had 
complications ranging from none to a combination of minor complications.  
 Group A Group B 
Primary end point: 
Total number of complications 
 
80 
 
79 
Secondary end points: 
 Major Complication 
 Minor Complication 
1 
79 
0 
79 
 Complication score at 6 weeks 
 Complication score at 6 months 
 Complication score at 1 year 
78 
31 
20 
70 
29 
25 
 Technical failure 1 1 
Table 6: Primary and secondary end points  
 6 weeks 6 months 1 year Removed/Death 
Group A 48 29 19 12 
Group B 44 34 22 9 
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7. Conclusion 
In summary, we believe the PEG vs. RIG trial is progressing well. Initial recruitment 
issues were addressed with amendments. There have been no serious and adverse 
events, and there is a detailed record keeping of any of these events (in keeping with 
ethical standards) were they to occur. The acceptance and follow up rate has been good 
with no loss to follow up recorded so far.  
We hope that the DMEC will be satisfied with the trial progress until now and will 
encourage its completion. 
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Appendix A: Serious Adverse Events  
To date, there has been no serious adverse event among the cohort of participants 
randomised in the trial. The deaths (n=7) were not unexpected among patients with 
advanced haematological/oncological disease. 
Months post procedure Diagnosis 
7 months Medulloblastoma 
2 months Low grade glioma 
13 months Metastatic medulloblastoma 
13 months Cardiac rhabdomyosarcoma 
6 months ALL 
5 months Menke's disease, seizures,progressive neuropathy 
5 months AML, Pre BMT 
 
Table 7: Characteristics of patients who died 
(ALL = Acute Lymphoblastic Leukaemia, AML = Acute Myeloid Leukaemia, BMT = 
Bone Marrow Transplant) 
 
 
 
 
 
 DMEC Report 
 184 
 
Appendix B: Meeting Agenda 
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1. Introduction and Apologies 
2. Apologies:  
3. DMEC presentation 
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b. Results update 
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d. Serious Adverse Events 
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4. Any other Business 
5. Plan Next meeting of DMEC
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